The Lattice (Official 3DHEALS Podcast): Recent Episodes
3DHEALS
Welcome to the Lattice podcast, the official podcast for 3DHEALS. This is where you will find fun but in-depth conversations (by founder Jenny Chen) with technological game-changers, creative minds, entrepreneurs, rule-breakers, and more. The conversations focus on how to use 3D technologies, like 3D printing and bioprinting, AR/VR, and In silico simulation, to reinvent healthcare and life sciences. This podcast will include AMA (Ask Me Anything) sessions, past Instagram Live interviews, press releases or updates from Pitch3D startups, select past virtual event recordings, and other direct engagements with our Tribe.
While there is no rule for our podcast content, the only rule we really follow is to provide our listeners with a maximized return on their attention and time investment.
Follow us on Facebook, Twitter, and Instagram @3dheals and check out the links in the show notes.
3DHEALS Links: https://linktr.ee/3dheals
A brain organoid that can learn to play Pac-Man sounds like a stunt until you realize what it represents: measurable learning, rewiring, and human-relevant neural function that animal models often fail to predict. We talk with Dr. Lowry Curley, founder of Luna LifeSci and former CEO and co-founder of Axosim (now 28 Bio), about why neuroscience drug development breaks so often and how NAMs are finally giving teams better tools to make safer calls earlier.
If you’re building in biotech, investing in drug discovery, or just trying to understand what replaces animal testing next, this conversation gives you a clear map of the technology, the incentives, and the milestones to watch. Subscribe, share this with a colleague, and leave a review with the biggest NAM question you want answered next.
Show notes: https://3dheals.com/episode-122-new-approach-methodologies-nams-with-dr-lowry-curley/
YouTube: https://youtu.be/suVxiYZgPVE
Send us Fan Mail
Support the show
Subscribe to our premium version and support the show.
Follow us:
Twitter
Instagram
Linkedin
3DHEALS Website
Facebook
Facebook Group
Youtube channel
About Pitch3D
Absorbable biomaterials have transformed modern medicine, enabling implants, sutures, and drug-delivery systems that safely degrade once their function is complete. Dr. Rao S. Bezwada has helped shape the field of bioresorbable polymers for more than three decades. As the inventor of Monocryl®, the absorbable suture that has generated more than $2 billion in worldwide sales, and the holder of more than 150 U.S. patents, his innovations have influenced everything from surgical sutures to next-generation biomaterials. In this episode of The Lattice, Dr. Bezwada joins Dr. Jenny Chen to discuss the science behind bioresorbable polymers, the chemistry that controls how materials degrade, and what the next generation of resorbable biomaterials could make possible.
⚠️ Disclaimer:
This podcast is for educational and informational purposes only. The views expressed do not constitute engineering, medical, or financial advice. The technologies and procedures discussed may not be commercially available or suitable for every case. Always consult with a qualified professional.
YouTube video:
Show notes: https://3dheals.com/episode-121-absorbable-biomaterials-with-dr-rao-bezwada/
Send us Fan Mail
Support the show
Subscribe to our premium version and support the show.
Follow us:
Twitter
Instagram
Linkedin
3DHEALS Website
Facebook
Facebook Group
Youtube channel
About Pitch3D
We explain what physical AI is and why it matters when AI can sense, decide, and act in the real world rather than just analyze data. We map where it shows up across healthcare today, what’s holding it back, and the trends that could make it the next big platform shift in medicine.
Check out our full guide on physical AI in healthcare here.
Send us Fan Mail
Support the show
Subscribe to our premium version and support the show.
Follow us:
Twitter
Instagram
Linkedin
3DHEALS Website
Facebook
Facebook Group
Youtube channel
About Pitch3D
If you have ever wondered why dentistry can feel both high-tech and oddly hand-built at the same time, this conversation connects the dots. We talk with Dr. Nabeel Cajee, an oral implantologist in Newport Beach and faculty at Torque Academy and Implant Ninja School, about what it really takes to bring digital dentistry into daily patient care without turning your practice into a science project. From the earliest days of open-source 3D printing to today’s clinical workflows, he breaks the ecosystem down into what actually matters: data capture, dental CAD design, and fabrication with dependable post-processing.
If you care about dental 3D printing, chairside CAD/CAM, guided implant surgery, or the future of restorative dentistry, subscribe, share this with a colleague, and leave a review with your biggest question about digital workflows.
Show notes: https://3dheals.com/episode-119-where-is-dental-3d-printing-with-dr-nabeel-cajee/
YouTube Video: https://youtu.be/FOKQNpMJjb4?si=DImMXMXEiNH5oheH
Send us Fan Mail
Support the show
Subscribe to our premium version and support the show.
Follow us:
Twitter
Instagram
Linkedin
3DHEALS Website
Facebook
Facebook Group
Youtube channel
About Pitch3D
Ossiform is on track to bring the first 3D printed resorbable bone implant to the US market. The company’s preclinical data showed full bone regeneration in six months. Monica Wellejus, Chief Commercial Officer of Ossiform, joins The Lattice to explain how a company built to personalize bone implants for craniomaxillofacial surgeries is pivoting to mass-produced bone implants for foot deformity, and why hospital finance teams, not just the surgeons, may decide whether this technology actually reaches patients.
⚠️ Disclaimer:
This podcast is for educational and informational purposes only. The views expressed do not constitute engineering, medical, or financial advice. The technologies and procedures discussed may not be commercially available or suitable for every case. Always consult with a qualified professional
00:00 Intro | Why 3D printed bone has not reached patients yet
02:08 Meet Monica Wellejus and Ossiform
05:41 How Ossiform prints bone substitutes using β-TCP ceramics
10:12 The long road to FDA clearance and U.S. market entry
14:03 Why Ossiform moved away from personalized implants
18:26 Listening to surgeons changed everything
23:47 Flatfoot reconstruction and Ossiform’s first clinical products
30:18 Fundraising, commercialization, and building a MedTech startup
38: 54 The hidden decision-makers in healthcare adoption
46:31 The future of bone regeneration, AI, and point-of-care manufacturing
Show notes: https://3dheals.com/episode-117-monica-wellejus-the-road-to-3d-printed-bone/
YouTube link: https://youtu.be/E8t35WzV7Eg?si=QH-XHfJDwihvqv6n
Send us Fan Mail
Support the show
Subscribe to our premium version and support the show.
Follow us:
Twitter
Instagram
Linkedin
3DHEALS Website
Facebook
Facebook Group
Youtube channel
About Pitch3D
What does it take to invent a technology that didn't exist before?
In this episode, host Dr. Jenny Chen sits down with Professor Paul Dalton, the inventor of melt electrowriting (MEW) and one of the rare "triple threats" in science: an inventor, educator, and futurist. This is also a conversation about science, creativity, and why MEW isn't just a technology but a movement.
Paul takes us from a boredom-filled childhood on a rural farm outside Perth, Australia, to the ophthalmic research lab where he helped build artificial corneas that restored sight to blind patients. He shares the moment a failing electrospinning experiment pushed him toward MEW instead — and the "breathless" discovery under the microscope that became MEW.
Along the way, Jenny and Paul explore:
- What electrospinning and melt electrowriting actually are, explained in plain language
- Why MEW pulls fibers instead of pushing them, and how it prints at one-tenth of a teardrop per hour
- The decades-long pursuit of clinical applications
- The open-source "MEWron" printer is bringing MEW to labs for a fraction of the cost of commercial machines
- The two kinds of makers — builders vs. users — and where the community is heading
- Paul's advice for clinicians and newcomers entering biofabrication
Plus, a remarkable offer for listeners at the end of this episode.
🔗 Show notes
YouTube recording: Coming soon
Send us Fan Mail
Support the show
Subscribe to our premium version and support the show.
Follow us:
Twitter
Instagram
Linkedin
3DHEALS Website
Facebook
Facebook Group
Youtube channel
About Pitch3D
Surgery is moving into a world where we can measure, simulate, and even rehearse before we ever touch a patient, but getting 3D surgical planning to feel “normal” inside a hospital is still a battle. We bring together a rare mix of voices across the ecosystem to explain what’s actually working, what’s still missing, and what it takes to scale medical 3D printing and virtual surgical planning without sacrificing safety or quality.
Event Page: https://3dheals.com/3d-surgical-planning/
Subscribe, share this with someone building a 3D program, and leave a review with the biggest blocker you see to making 3D planning routine.
Send us Fan Mail
Support the show
Subscribe to our premium version and support the show.
Follow us:
Twitter
Instagram
Linkedin
3DHEALS Website
Facebook
Facebook Group
Youtube channel
About Pitch3D
This is our second episode recorded at the Materialise conference. Our guest for this episode is no other than the CEO of Materialise Brigitte de Vet-Veithen. It is a pleasure for me to be able to conduct this interview, because Materialise is such a legendary company that has spent 35 years building the software and services infrastructure behind patient-specific implants, surgical planning, and point-of-care manufacturing. We also got to know Brigitte as a person and the new leader of the company. Importantly, we covered the metrics that signal adoption, challenges to scale beyond the halo case, and her vision for the industry. In my opinion, this is perhaps one of the most important conversations for the medical 3D printing industry in 2026.
Highlights of this episode:
• Brigitte's journey from MedTech leadership to being the CEO at Materialise
• Why reimbursement is the clearest signal of adoption for medical 3D printing
• Building health economics evidence for patient-specific devices when every case is unique
• Helping physicians shift mindset toward pre-operative planning and new workflows
• The move from “3D printing company” to solution partner for specific clinical needs
• Why robots and surgical guides coexist, especially in ambulatory surgery centers
• How AI compresses lead times and expands access for trauma patients
• Mass personalization roadmap across orthopedics, CMF, pediatrics, respiratory, and structural heart
• Global adoption differences and why imaging availability sets the pace
• Investment priorities across education, evidence generation, R&D, and M&A
Please listen to the disclaimer at the end of this podcast.
Show Notes: https://3dheals.com/episode-114-interview-with-brigitte-de-vet-veithen-ceo-of-materialise/
YouTube: https://youtu.be/9PgME2RAmog?si=t-0X_DkrBdRg4MHe
Send us Fan Mail
Support the show
Subscribe to our premium version and support the show.
Follow us:
Twitter
Instagram
Linkedin
3DHEALS Website
Facebook
Facebook Group
Youtube channel
About Pitch3D
This is one of two episodes we have recorded during our trip to Leuven Belgium for the Materialise 2026 Conference, focusing on 3D planning and 3D printing in hospitals. We talked with Dr. Tristan Remcharan about how pediatric cardiology imaging can become something you can literally hold, using 3D segmentation and 3D printing to make congenital heart disease easier to plan, teach, and explain. We also dig into the 2D versus 3D generational divide and the real-world funding hurdles that decide whether point-of-care 3D becomes routine care.
Show notes: https://3dheals.com/episode-113-how-3d-printing-explains-the-unexplainable-with-dr-tristan-ramcharan/
YouTube Video: https://youtu.be/eNUQWwJq5HM?si=3QhxXxvvUaEhO1MD
The 3D cardiac printing program at Birmingham Children's Hospital is funded by charitable donations.
To support Tristan's works directly: Birmingham Children's Hospital Charity — https://www.bch.org.uk/appeal/donate
Donate to the 3D cardiac printing program
Send us Fan Mail
Support the show
Subscribe to our premium version and support the show.
Follow us:
Twitter
Instagram
Linkedin
3DHEALS Website
Facebook
Facebook Group
Youtube channel
About Pitch3D
You can learn a lot about the future of healthcare by watching how a single pill gets made. From a small office in London, we sit down with Prof Alvaro Goyanes, co-founder and CEO of FabRx, to unpack how 3D printed pharmaceuticals are turning personalized medicine from an idea into a working system. If you’ve ever wondered why patients still get forced into a handful of standard doses, this conversation shows what changes when medicine becomes software-driven and printable on demand.
We talk about what FabRx is building, why they’ve stayed deeply research-led while pushing toward clinical application, and how partnerships with hospitals are translating 3D printing into real studies. We also get specific about the compounding pharmacy workflow: “pharma ink” syringes prepared ahead of time, doses selected in software, and tablets printed with controls that reduce manual steps and help cut inconsistency. It’s a practical look at personalized drug manufacturing for therapies that need flexible dosing across pediatrics, elderly care, hormones, and more.
Quality is the backbone of everything here, so we dig into traceability, weighing each unit, pressure-sensing to catch extrusion problems early, camera systems that verify prints, and where AI inspection and near-infrared methods fit in. We zoom out to the policy layer, including the UK’s move toward distributed point-of-care manufacturing and how regulators in Europe and the US are beginning to shape guidance for 3D printing in pharmacies. Then we end on a wild but serious frontier: why NASA cares about printing medicines in space, where supply chains and gravity don’t cooperate.
If you care about personalized medicine, 3D printing in healthcare, and the future of compounding pharmacies, hit subscribe, share this with a friend in pharma or medtech, and leave a review telling us what application you want to see next.
About Our Guest:
Alvaro Goyanes is the co-founder and CEO of FABRX, the first company dedicated to developing 3D printing technology for the fabrication of personalized medicines and medical devices. He is also an Honorary Associate Professor at University College London- School of Pharmacy (UK) and an Associate Professor at the Faculty of Pharmacy, University of Santiago de Compostela (Spain).
A pioneer in the field, Alvaro was among the first researchers to explore the potential of 3D printing for manufacturing oral dosage forms and medical devices. Recognized as a world expert in 3D-printed medicines, he has been listed among the World's Most Highly Influential Researchers by Web of Science for six consecutive years since 2019.
Alvaro holds a PhD in Pharmaceutics from the University of Santiago de Compostela and previously worked as a Registered Pharmacist for three years, giving him firsthand insight into the needs of community pharmacy.
Show notes: Coming soon
YouTube: Coming soon
Send us Fan Mail
Support the show
Subscribe to our premium version and support the show.
Follow us:
Twitter
Instagram
Linkedin
3DHEALS Website
Facebook
Facebook Group
Youtube channel
About Pitch3D
Neurotech is the category most investors whisper about and then walk away from: too technical, too regulated, too slow. We wanted to talk to someone who leans in anyway, so I sat down with Varun Turlapati, founder of Chanakya Capital, to hear how he’s building an early-stage fund dedicated to neurotech devices and why he thinks the “long horizon” objection often misses what’s actually happening on the ground.
We unpack Varun’s path from software engineering into venture capital, including the mindset shift from analysis paralysis to fast iteration with smart guardrails. From there, we widen the frame on what neurotech means. Yes, brain-computer interfaces matter, but we also get into neuromodulation, bioelectronics, and the nervous system as the body’s command network, linking the brain, gut, and heart, and addressing disease. That lens turns “niche” into “everyone with a brain,” and it changes how you think about markets, clinical impact, and investable product strategy.
Varun also shares the practical mechanics of deep tech investing: how he triages an 80+ company pipeline, separates “interesting” from “investable,” and brings in PhD scientists, physicians, and specialist advisors to evaluate clinical workflows and real differentiation. We dive into real examples across neuroprosthetics, Alzheimer’s, ADHD, and autism wearables, and a smart shunt for hydrocephalus, plus how regulatory signals like Breakthrough Device Designation can reshape the risk profile.
If you care about neurotech startups, medical devices, FDA pathways, or where venture capital goes after AI becomes commoditized, this conversation will sharpen your evaluation of both science and execution. Subscribe to Lattice, share this with a founder or investor who’s curious about neurotech, and leave a review with the biggest question you still have about building in this space.
Show notes: https://3dheals.com/episode-110-neurotech-investing-with-varun-turlapati-chaanakya-capital/
YouTube recording: coming soon
Send us Fan Mail
Support the show
Subscribe to our premium version and support the show.
Follow us:
Twitter
Instagram
Linkedin
3DHEALS Website
Facebook
Facebook Group
Youtube channel
About Pitch3D
Everyone talks about printing organs, but the closest thing to real impact often starts with something less flashy and far more practical: the materials. We bring together founders and operators working across bioprinted implants, structural bone substitutes, cryopreserved tissue models, and natural biopolymer manufacturing to answer one question that matters: what actually makes advanced biofabrication translate from bench to bedside?
We dig into bone regeneration and why scaffolds fail when they can’t balance strength, vascular support, and predictable resorption. You’ll hear how absorbable polyurethane platforms aim to avoid acidic degradation while letting teams program mechanics and timelines, plus how 3D printed beta-tricalcium phosphate ceramics can deliver structural consistency and then remodel into native bone. The conversation stays grounded in the realities that decide adoption: predicates and evidence expectations for FDA 510(k), the heavier burden of EU MDR, and the uncomfortable truth that clearance doesn’t guarantee reimbursement.
Then we shift to new approach methodologies for drug development, where cryobioprinting tackles the biggest blocker in bioprinted tissues: logistics. If tissues can be frozen, inventoried, shipped, and used on demand, bioprinting becomes a consumable workflow instead of an artisanal one-off. We close with a candid translation playbook for natural biopolymers and a high-volume pediatric use case: dissolvable chitosan ear tubes designed to reduce repeat surgeries, plus the pricing and coverage strategy needed to make that upgrade viable.
Subscribe, share this with a builder in medtech or biotech, and leave a review with your biggest takeaway: which bottleneck matters most right now, materials, regulation, reimbursement, or scale-up?
Event link: https://3dheals.com/bench-to-bedside-bioprinting-innovations/
YouTube highlights: Stay tuned
Send us Fan Mail
Support the show
Subscribe to our premium version and support the show.
Follow us:
Twitter
Instagram
Linkedin
3DHEALS Website
Facebook
Facebook Group
Youtube channel
About Pitch3D
We track the biggest healthcare 3D printing stories from March 2026, from bioprinted organs and sustainable bioinks to FDA-cleared implants and hospital point-of-care wins. We also look at how 3D printed cancer tools, training models, microrobots, and AI quality control are moving from research into real clinical and manufacturing workflows.
• bioprinted uterus model for preterm labor drug testing and future personalization
• ENLIGHT pancreas project using volumetric bioprinting and long viability gels for diabetes research
• vascularized adipose tissue implants for soft tissue repair and breast reconstruction
• Singapore biofabrication roadmap focused on sustainable biomaterials and circular supply chains
• FDA 510(k) cleared titanium spinal implant plus trends in lumbar cage materials and coatings
• EU MDR certified denture manufacturing and implications for scaled dental 3D printing
• 3D printed breast cancer locator improving surgical margins with patient-specific guides
• 3D printed metastasis research platform showing fibroblast protection in blood flow stress
• brain phantoms and beating heart simulators for realistic surgical training
• bioprinted cardiac spheroids for studying SARS-CoV-2 heart infection and drug testing
• microrobots, AI defect prediction, volumetric production methods, and micro-scale printers
• hospital-made rehab devices cutting costs and a reality check on AI-driven implants
Please subscribe for more future updates and let us know if anything is missing or incorrect.
Complete show notes, including links to all articles mentioned in this podcast, are here.
Send us Fan Mail
Support the show
Subscribe to our premium version and support the show.
Follow us:
Twitter
Instagram
Linkedin
3DHEALS Website
Facebook
Facebook Group
Youtube channel
About Pitch3D
What happens when a hospital needs a simple part but the supply chain takes weeks or months to deliver it? Dr. Stephan Ryan, physician and co-founder of PolyUnity, set out to solve that problem by helping hospitals produce parts themselves through safe, compliant 3D printing. In this episode, Stephen Ryan shares how early clinical experiences and an academic 3D printing lab evolved into a platform designed to help hospitals manufacture equipment on demand. The COVID pandemic accelerated that vision, exposing major supply chain gaps and pushing the team to rapidly scale production. Stephen Ryan explains how those lessons shaped PolyUnity’s approach to building practical additive manufacturing systems within the realities of healthcare procurement, regulation, and hospital workflows.
Bullet points:• Defining PolyUnity’s mission to democratize hospital 3D printing with compliant workflows
• The rural hospital supply chain problem that sparked the original research project
• How COVID accelerated real-world production and forced end-to-end process design
• Why post-pandemic red tape returned and how it shaped the software moat
• Bootstrapping a medtech startup in Canada with long procurement cycles
• Building a small team and staying capital efficient through iterative deployment
• Good and "bad" ideas for hospital 3D printing applications
• High-ROI case applications that avoid big spend
• Distributed manufacturing hubs and the practical path toward on-site production
• The wisdom of choosing simple over complexity.
• Post-processing bottlenecks and what are potential solutions.
• Personal transformation from clinician to entrepreneur.
Show notes: https://3dheals.com/teleporting-medicine-with-3d-printing-dr-stephen-ryan-of-polyunity-interview/
Full video interview: https://youtu.be/cO7mTr5GLJ8?si=icmU03OI1cPDZJL9
About our guest:
Dr. Stephen Ryan is a physician, entrepreneur, and the co-founder and Chief Medical Officer of PolyUnity, a Canadian health tech company focused on lowering the barrier for hospitals to adopt 3D printing through its i3D platform and solutions. His work centers on building software, quality systems, and distributed print capacity so that hospitals can reliably order and receive end use 3D printed parts, from simple fixtures to clinically relevant devices, within existing procurement and regulatory frameworks.
Send us Fan Mail
Support the show
Subscribe to our premium version and support the show.
Follow us:
Twitter
Instagram
Linkedin
3DHEALS Website
Facebook
Facebook Group
Youtube channel
About Pitch3D
We map the biggest shifts in healthcare 3D printing this month, from emissions safety to custom eyewear, implant surfaces, microfluidics, and space-based biomanufacturing. We weigh promise against risk and share where standards and design can close the gap.
• emissions from desktop and industrial printers and why they matter
• safeguards for vulnerable groups and safer materials and testing
• face-scan eyewear, on-demand manufacturing, and fashion collaborations
• implant surface roughness, porosity, coatings, and clinical outcomes
• ceramic, titanium, and PEEK devices for spine, ankle, and CMF
• microfluidics for diagnostics and microneedle vaccines and immunotherapy
• digital microfluidics and 3D cell culture for faster R&D
• microgravity biomanufacturing and what space enables for medicine
See blog post related to this podcast: https://3dheals.com/the-lattice-feb-2026-advanced-devices-custom-eyewear-and-hidden-health-risks-of-3d-printing/
Send us Fan Mail
Support the show
Subscribe to our premium version and support the show.
Follow us:
Twitter
Instagram
Linkedin
3DHEALS Website
Facebook
Facebook Group
Youtube channel
About Pitch3D
We share how a decade of soft robotics, open APIs, and relentless iteration turned a 3D-printed prototype into a durable, touch-sensing bionic hand used by amputees and robots. Stories of failure, funding, and firsts reveal how speed, sensation, and design choices translate to real lives and real factories.
• early 3D printing wins and durability limits
• shift to soft robotics, silicone overmolding, carbon fiber reinforcement
• founding spark, Ecuador trial, and move from academia to company
• SBIR lifeline, failed crowdfunding, then coverage and clinical validation
• speed, grip force, and touch sensors compared with the market
• open API for control and data streaming in minutes
• robotics crossover in automotive and research labs
• access initiatives via the Ability Fund and global impact
• manufacturing scale plans and ethical boundaries
• practical founder habits, grit, and advice to start now
Please listen to the disclaimer at the end of this podcast
Show notes: https://3dheals.com/aadeel-akhtar-bionic-hands-for-humans-and-robots-the-psyonic-story/
YouTube: https://youtu.be/mDVMRhjXr0w?si=qoZrScjaC6nbiPMJ
About our guest:
Dr. Aadeel Akhtar, CEO of PSYONIC, founded the company to create advanced, accessible bionic limbs after meeting a young girl in Pakistan who was missing a limb. PSYONIC's bionic Ability Hand is the fastest on the market, impact-resistant, and the first to provide a sense of touch. It is also covered by Medicare and is being used by humans and robotics companies globally, including NASA, Meta, Mercedes, and Google. Dr. Akhtar earned a Ph.D. in Neuroscience and an M.S. in Electrical & Computer Engineering from the University of Illinois, along with a B.S. in Biology and an M.S. in Computer Science from Loyola University Chicago. He’s been recognized by MIT Technology Review and Newsweek and secured a 3-shark deal on Shark Tank.
Send us Fan Mail
Support the show
Subscribe to our premium version and support the show.
Follow us:
Twitter
Instagram
Linkedin
3DHEALS Website
Facebook
Facebook Group
Youtube channel
About Pitch3D
We track a month of fast-moving news in healthcare 3D printing, from organ-scale bioprinting programs and ARPA-H’s funding model to point-of-care tools already entering clinics. The throughline is clear: vascularization, immune compatibility, and scale are converging with real-world deployment.
• UT Southwestern’s organoid-plus-bioprinting strategy for durable liver tissue
• Carnegie Mellon’s consortium on vascularization, immune control, and scale
• ARPA-H’s moonshot funding model is accelerating medical innovation
• Aspect Biosystems and Novo Nordisk’s bet on curing diabetes
• Cost shift from chronic management to curative therapies
• Near-term point-of-care printing: Curify Labs and AZORG integrations
• Key milestone to watch: functional vascular networks
• Outlook as research, industry, and funding align
Remember, this podcast is for educational and informational purposes only
The views expressed do not constitute engineering, medical, or financial advice. The technologies and procedures discussed may not be commercially available or suitable for every case. Always consult with a qualified professional
Shownotes: https://3dheals.com/lattice-news-arpa-h-organ-moonshots-point-of-care-manufacturing-and-more/
Send us Fan Mail
Support the show
Subscribe to our premium version and support the show.
Follow us:
Twitter
Instagram
Linkedin
3DHEALS Website
Facebook
Facebook Group
Youtube channel
About Pitch3D
A crowded JP Morgan week can blur into noise, so we built a quieter stage to focus on what actually moves healthcare forward: 3D software‑planned care, on‑demand manufacturing, and proof that patients and payers can feel. Recorded live in San Francisco, this special episode brings founders and investors together to show how 3D data and advanced manufacturing are turning personalization into a scalable, measurable reality.
We start with a rare blueprint for value in spine surgery: virtual planning, patient‑specific 3D printed implants, and post‑op analytics that cut two‑year reoperations by 74% while compressing lead times from eight weeks to eight days. From there, the conversation widens fast. Hear how microarray patches with five‑micron precision enable co‑delivery without co‑formulation and factory‑level scale; how therapeutic hardware draws on bone biology to reduce revisions; how personalized pessaries bring dental‑style business models to women’s health; and how drill‑free, patient‑specific dental implants fit in six days without a single turn of a drill.
We also explore the frontier where human recovery meets robotics. A single bionic hand platform serves amputees and humanoid robots, translating human manipulation data into industrial automation while staying Medicare‑covered. On the R&D side, vascularized tissues and cryobioprinted models aim to fix translational failure by making complex biology reproducible and shippable. Structural biopolymer fibers unlock sutures, meshes, and sports medicine implants with clean‑room scale. A countertop system automates cell therapy final formulation so community hospitals can treat more patients safely. And a new biomanufacturing approach targets IVIG supply constraints by achieving human‑like B‑cell densities in ultrafast 3D printed bioreactors. We close with high‑viscosity inkjet that prints materials traditional jets can’t, powering durable dental parts and microneedle patches at true production speeds.
Along the way, an investor panel compares notes on 2026: where exits might return, where non‑dilutive capital is shifting, and what it now takes to earn a check—clear end‑user value, defensible tech, and a distribution edge. If you care about medtech, bioprinting, cell and gene therapy delivery, or the future of personalized care, this is your field guide to what’s working right now.
If this conversation sparks new ideas or a partnership you want to pursue, subscribe, share the episode with a colleague, and leave a quick review telling us which breakthrough you want to hear more about.
Event speaker biographies: https://3dheals.com/life-in-3d-investing-in-the-next-frontier/
On-Demand Video (Pending publication): https://3dheals.com/courses/
Pitch 3D Application link: https://3dheals.com/pitch3d/
Send us Fan Mail
Support the show
Subscribe to our premium version and support the show.
Follow us:
Twitter
Instagram
Linkedin
3DHEALS Website
Facebook
Facebook Group
Youtube channel
About Pitch3D
We explore how to move IVIG from donor scarcity to on‑demand manufacturing with tissue‑engineered bioreactors, and why that shift could lower costs, expand access, and improve consistency. We dig into polyclonal advantages, regulatory guardrails, scaling plans, and what success would mean for complex biologics beyond antibodies.
• Defining a bioreactor that recreates human tissue niches
• Why polyclonal IVIG remains essential across 100+ conditions
• Limits of donor‑dependent plasma supply and regional variability
• Complex therapeutics as a new manufacturing category
• Cost targets of 10–100x reduction and CapEx shrink
• Coffee‑cup reactors and near‑term validation milestones
• Quality metrics including pathogen panels and glycosylation
• Donor variability, blending strategies, and future immortalization
• Clinical impact of moving from rationing to earlier use
• Funding update and industry partnerships
Please listen to the disclaimer at the end of this podcast.
Show notes: https://3dheals.com/episode-102-can-bioprinting-bioreactor-reshape-the-future-of-immunology/
About our guests:
Dr. Melanie Matheu is an immunologist, inventor, and biotechnologist recognized for pioneering work in high-resolution tissue engineering and human immunology. She received her PhD in Physiology and Biophysics with a focus on Immunology from UC Irvine and completed postdoctoral training at VIB (Ghent University, Belgium) and UC San Francisco, where she specialized in 2-photon imaging and cellular immune responses. As founder of Prellis Biologics, Dr. Matheu brought forward laser-based tissue bioprinting to solve complex challenges in organ transplantation and therapeutic antibody discovery. She later co-founded Lyric Bio, where she serves as Chief Scientific Officer, advancing scalable biomanufacturing platforms and rapid human immune system modeling. Dr. Matheu has authored numerous peer-reviewed publications, holds multiple patents, and is a passionate advocate for innovation at the intersection of immunology and bioengineering.
Kevin Shannon (Kayj) holds a degree in Molecular Biology from Princeton University and a MBA from Stanford Graduate School of Business. Kayj has held positions spanning the biotech ecosystem including start-ups, big pharma, venture capital, and consulting. As part of Corporate Strategy at Amgen, he worked with Amgen’s C-Suite to shape long-term strategy, built partnerships in novel therapeutic modalities, and led investments in emerging categories including cell & gene therapy, antibody engineering, single cell analysis, and quantum computing. Kayj has also consulted for multiple VC funds where he developed investment theses and performed diligence in emerging technologies. Most recently, led business development for Zafrens, raising >$20M and securing two pharma company partnerships.
Kayj was first introduced to Melanie and the Prellis bioprinting technology when she brought him on as a consultant to evaluate initial applications for the company’s technology. Because of their strong working relationship and the remarkable nature of the technology, Kayj is excited to reunite with Melanie and join Lyric as CEO.
Send us Fan Mail
Support the show
Subscribe to our premium version and support the show.
Follow us:
Twitter
Instagram
Linkedin
3DHEALS Website
Facebook
Facebook Group
Youtube channel
About Pitch3D
In this episode, Alyssa Huffman, CEO and co-founder of Allumin8, shares the six-year journey behind a first-of-its-kind 5.5 mm porous, 3D-printed pedicle screw. We discussed how Allumin8 earned FDA clearance and why design details matter for fatigue, fixation, and fewer revisions. We also map a path toward therapeutic hardware that integrates orthobiologics without slowing surgeons down.
Critical questions addressed:
Why does 5.5 mm matter so much?
How does Gaussian topography support bone ingrowth?
What are some of the lessons from fatigue testing and post-processing?
What are the additive vs milled manufacturing trade-offs?
What was Allumin8's FDA journey and strategy?
When and how do orthobiologics add value?
How did Alyssa build a purpose-aligned team and investor base?
What are some practical founder advice on equity and boards?
What is on Alyssa's wishlist for the future of orthopedic implants?
Please listen to the disclaimer at the end of this podcast.
Stay tuned for our show notes for relevant links, video highlights, glossary of terms, and more resources to enjoy this episode.
Send us Fan Mail
Support the show
Subscribe to our premium version and support the show.
Follow us:
Twitter
Instagram
Linkedin
3DHEALS Website
Facebook
Facebook Group
Youtube channel
About Pitch3D
Imagine holding a child’s heart in your hands and seeing the exact path a surgeon must take before a single incision. That shift from uncertainty to clarity frames this conversation on how 3D printing, virtual reality, and advanced imaging are transforming pediatric cardiology. Our speakers show how AI-assisted segmentation, multimodality fusion, VR rehearsal, and rapid mixed-reality planning are reshaping preoperative strategy and improving communication with families.
Sarah Ptashnik of Materialise opens with the modeling perspective, walking through how CT, MRI, echo, and cath-lab 3DRA are turned into precise hollow heart models that guide baffles, conduits, and catheter routes. Nicholas Jacobson of Tangible Vet Tech brings the design and device lens, sharing how voxel modeling, hemocompatible printing, and cross-species research accelerate innovation for complex repairs. Dr. Ravi Ashwath of Baylor College of Medicine and Christus Children’s Hospital explains how advanced MRI, CT, and VR planning shorten procedure time and help teams anticipate complications in demanding congenital cases. Dr. Shafkat Anwar of UCSF Benioff Children’s Hospitals expands on fusion imaging and mixed reality for high-risk interventions, while Dr. Jenny Zablah of Children’s Hospital Colorado highlights how 3D tools improve strategy for pulmonary vein stenosis and other complex anatomies.
Together, they explore real cases in which 3D models reshaped surgical plans, revealed hazards that imaging alone missed, and enabled bench-testing of devices before entering the cath lab. The discussion covers sterilizable materials, device libraries, accuracy checks, and how VR and AR support rapid decision-making when there is no time to print.
If you are building or refining a 3D program, you will find practical guidance on quality control, when to print versus stay digital, and how to scale these tools across a health system. 3D technologies are becoming the standard for safer, smarter, and more human cardiac care.
See show notes and video highlights
Send us Fan Mail
Support the show
Subscribe to our premium version and support the show.
Follow us:
Twitter
Instagram
Linkedin
3DHEALS Website
Facebook
Facebook Group
Youtube channel
About Pitch3D
In this episode, Dr. Karolina Valente, Founder and CEO of VoxCell BioInnovation, discusses her journey in biotechnology, focusing on 3D bioprinting and its impact on cancer research and drug discovery. She shares insights into her leadership at VoxCell, the company's growth, and the accolades it has received. Dr. Valente also talks about the importance of partnerships, the future of biotechnology, and her personal experiences that drive her passion for innovation.
Questions answered:
- How did Karolina first get involved with entrepreneurship and founding VoxCell BioInnovation?
- What was it like to start a career across multiple continents? (From Brazil to Canada)
- How to switch the hat from a scientist to a company founder?
- What were some of the early milestones in the VoxCell journey that were impactful to the company today?
- What is the core technology of the 3D bioprinting platform at VoxCell?
- How does VoxCell’s technology address the Vascular Challenge in cancer research?
- What kind of data do you provide in preclinical studies, and how does it compare to animal models?
- How does Karolina navigate and build company culture at VoxCell?
- What advice does Karolina have for young entrepreneurs and students in school?
See full show notes, links, and resources.
Send us Fan Mail
Support the show
Subscribe to our premium version and support the show.
Follow us:
Twitter
Instagram
Linkedin
3DHEALS Website
Facebook
Facebook Group
Youtube channel
About Pitch3D
Summary
In this conversation, Jenny Chen explores the complex implications of ChatGPT on intelligence and education. She emphasizes the need for careful consideration of the technology's impact, particularly in academic settings, and discusses the broader context of a technological revolution that may have both positive and negative consequences.
Takeaways
- Is ChatGPT making us dumb?
- This is a much more complicated question.
- ChatGPT is problematic, especially for students.
- We should consider this carefully and thoughtfully.
- We're at a juncture of technological revolution.
- Revolutions typically will have some casualties.
- How can we use this new tool effectively?
- Maximize our productivity without diminishing humanity.
- Not causing something unthinkable, like being ruled by AI.
- The good and evil of this very potent tool.
Show Notes:
https://3dheals.com/is-chatgtp-or-ai-making-us-stupid-two-cents/
Send us Fan Mail
Support the show
Subscribe to our premium version and support the show.
Follow us:
Twitter
Instagram
Linkedin
3DHEALS Website
Facebook
Facebook Group
Youtube channel
About Pitch3D
How well do we really understand the body? For decades, surgeons have relied on static scans and flat 2D models to plan procedures. Gilly Yildirim believes it’s time to expand our view to more dimensions. As founder and CEO of Vent Creativity, he is bringing together point clouds, digital twins, and physics-based AI to capture movement with a level of precision that static imaging is far from.
In conversation with Jenny Chen, Gilly Yildirim describes how his team built a platform that sees the body not as a collection of bones, but as a dynamic system of forces and interactions. Their software models the physics of ligaments, cartilage, and bone to predict how a patient’s knee will behave before surgery even begins. The goal is to give surgeons a more clear and reliable picture of what they’re working with.
Yildirim shares the thinking that shaped his company’s approach. The team’s goal wasn’t to design a product, but to build a service that integrates into real clinical practice. Vent’s technology includes Minerva, an adaptive AI engine trained on real anatomical data. It powers Hermes, an FDA-cleared knee planning tool, and inVENT, a cloud platform that lets surgeons explore patient-specific digital twins in full 3D.
Gilly Yildirim has 20 years of experience in orthopedics, so he has unique understanding of the clinical and technical sides of surgical innovation. He discusses how biomechanics, imaging physics, and computational modeling converge within Vent’s framework to create accurate, reproducible results. The same methods used to map a knee could soon extend to hips, shoulders, cardiac systems, and even to full-body digital twins that integrate data across multiple organs and modalities. His work points toward a future where medical planning is not based on snapshots, but on simulations that mirror the patient’s unique physiology.
This episode offers a deep, imaginative look at how AI, physics, and human creativity are coming together to build the next generation of surgical intelligence.
Send us a text
Support the show
Subscribe to our premium version and support the show.
Follow us:
Twitter
Instagram
Linkedin
3DHEALS Website
Facebook
Facebook Group
Youtube channel
About Pitch3D
Microfluidics has long promised to reshape diagnostics, drug discovery, and laboratory science. Microfluidics is about manipulating how tiny amounts of liquid move through channels no wider than a human hair; a "lab on a chip" diagnostic. Now imagine being able to 3D print those channels instead of painstakingly etching them. Paul Marshall, CEO of Rapid Fluidics, is working to improve the norm by applying additive manufacturing to the design and production of microfluidic systems.
In this episode, Jenny Chen speaks with Marshall about how 3D printing enables fluidic devices with architectures that cannot be produced through conventional techniques. Traditional fabrication locks researchers into rigid patterns and flat geometries. Paul's work extends beyond basic microfluidics.
His team creates remarkably detailed anatomical models by converting medical imaging data into functional vascular systems that mimic human biology. These models provide alternatives to animal testing and training platforms for medical procedures. They've also worked on embedding electronics directly into microfluidic devices, creating "smart" systems that can measure biological changes in real-time. Their work clearly demonstrates the potential of infusing engineering precision with scientific imagination.
Paul Marshall reflects on the growth of his career as a founder by detailing the progression from experimental prototypes to a growing enterprise serving research communities. Marshall launched this venture at the beginning of the COVID-19 pandemic, a seemingly unpromising time to start a business. However, as diagnostic companies pivoted to develop coronavirus tests, the demand for rapid prototyping exploded. Now five years later, Rapid Fluidics serves global healthcare giants from their base in Newcastle, England, while planning expansion to the United States.
This conversation offers a perspective on microfluidics that goes beyond the traditional. If you’ve ever wondered how big breakthroughs emerge from small scales, this episode makes the case that the tiniest channels can carry some of the most exciting ideas.
Send us a text
Support the show
Subscribe to our premium version and support the show.
Follow us:
Twitter
Instagram
Linkedin
3DHEALS Website
Facebook
Facebook Group
Youtube channel
About Pitch3D
What truly makes bioprinting possible isn’t just 3D printers. It's important to understand the materials that flow through them. In this virtual event, we explored the world of biomaterials for tissue engineering and how chemists are shaping the future of regenerative medicine through careful material design.
On demand course: https://3dheals.com/courses/advanced-biomaterials-for-3d-printed-medtech-and-biotech/
YouTube highlights: Here
Our editorial event recap: https://3dheals.com/what-are-the-latest-advances-in-biomaterials-for-3d-bioprinting/
Bowman Bagley, Vice President of Commercial at CollPlant, introduces recombinant human collagen made from genetically modified tobacco plants. This approach avoids animal-derived components while improving performance. The collagen can be concentrated to higher levels and modified more effectively than traditional sources, producing structures that support tissue regeneration while staying printable.
Dr. Janaina Dernowsek, Co-Founder and CEO, takes us inside the Quantis Biotechnology platform, where her team has developed a way to create human extracellular matrix (ECM) from bioprinted tissue constructs. By using dermal-like tissues as bioreactors, they harvest complex protein networks that promote cell growth without triggering inflammation, opening new possibilities for skin regeneration and beyond.
Dr. Riccardo Levato, highlights volumetric bioprinting, a method that uses patterned light to form entire structures within seconds. His team combines material chemistry with advanced design techniques, allowing printers to respond to cellular environments in real time and build vascular networks that support tissue function.
Dr. Jasper Van Hoorick, Co-Founder and CEO of BIO INX, addresses the need for standardization and confronts "biofabrication deception". He describes how his company creates consistent, high-performing materials tailored to specific printing technologies. This work helps make bioprinting more reliable and accessible for researchers worldwide.
Finally, Dr. Scott Taylor, CTO at Poly-Med, discusses absorbable synthetic polymers that provide mechanical support during tissue regeneration and then safely degrade once their job is done.
Whethe
Send us a text
Support the show
Subscribe to our premium version and support the show.
Follow us:
Twitter
Instagram
Linkedin
3DHEALS Website
Facebook
Facebook Group
Youtube channel
About Pitch3D
What happens when advanced mathematics meets manufacturing? The result is a new way of creating products that range from record-breaking running shoes to life-changing medical devices.
In this episode, we sit down with Elissa Ross, mathematician and CEO of Metafold 3D, to explore how her company is using mathematics to reshape design and manufacturing. Metafold’s platform is built on geometric intelligence which is her company's novel approach that transforms shapes into data that can be analyzed and improved. Instead of simply representing objects the way traditional CAD software does this method allows engineers to simulate and optimize designs with greater speed and accuracy.
At the core of this approach is implicit modeling with signed distance functions. While it may sound highly abstract, it has very practical applications. This technique allows manufacturers can run thousands of simulations in the time it would normally take to analyze a single design. The result is shorter development cycles and products that perform better in the real world.
Ross also reflects on her journey building Metafold, from its early focus on 3D printing to its current role serving major industries. She explains how their API-first platform gives customers the flexibility to solve specific challenges, such as analyzing tolerances, reusing similar parts, or predicting how designs will hold up under different conditions.
Whether you are a designer, an engineer, or simply curious about how mathematics is shaping the technologies around us, this episode offers a thoughtful look at the future of manufacturing intelligence.
Shownotes: Check back soon
Podcast Engineer: Faith Fernandes
Send us a text
Support the show
Subscribe to our premium version and support the show.
Follow us:
Twitter
Instagram
Linkedin
3DHEALS Website
Facebook
Facebook Group
Youtube channel
About Pitch3D
Cartilage injuries sideline millions every year, yet current treatments often fail to restore long-term function. In this episode, Dr. Nathan Castro and Dr. Ben Holmes, co-founders of Nanochon, explain how they are tackling this challenge with a 3D-printed implant designed not only to replace damaged tissue but to help it regrow. What began as a collaboration in a graduate lab has grown into a company now preparing for its first human clinical trial.
Their journey began at George Washington University in Dr. Grace Zhong’s tissue engineering lab, where the freedom to explore outside of strict grant-funded projects encouraged bold experimentation. Nathan even purchased specialized materials with his own money to expedite early tests. That investment in curiosity became the foundation for a technology that could change how orthopedic surgeons treat cartilage damage.
Nanochon’s implant blends strength with biology. It pairs a smooth articular surface with a porous lattice that integrates directly with surrounding tissue. Traditional approaches, Nathan explains, can be “like filling a pothole with jelly.” By contrast, their device provides stability without the need for sutures or pins. Despite being less than half the thickness of conventional implants, it requires two to three times more force to dislodge, which may result in shorter recovery times for patients.
From there, the company advanced step by step. They began with small animal studies in rats, progressed to goats, and finally proved the implant’s strength and integration in horses. These results not only built regulatory confidence but also convinced investors. With Health Canada’s approval for its first-in-human trial, Nanochon stands on the edge of translating a decade of persistence into clinical impact.
Ben and Nathan also reveal the realities of building a medical device startup, including raising funds during tight markets, meeting ISO 13485 quality standards, and learning to manage external contractors. This conversation is a rare look behind the curtain of medtech entrepreneurship. It shows how innovation happens in steady layers, built one on top of another, much like 3D printing itself.
Shownotes
Podcast Engineer: Faith Fernandes
Send us a text
Support the show
Subscribe to our premium version and support the show.
Follow us:
Twitter
Instagram
Linkedin
3DHEALS Website
Facebook
Facebook Group
Youtube channel
About Pitch3D
What if your medication could be made just for you? No more pill overload and no more awkward dosing workarounds. Just the exact treatment you need when you need it. That is the promise of 3D printed pharmaceuticals.
Drug manufacturing has relied on a one-size-fits-all model for decades. Nearly half of all medications lack proper formulations for children and seniors are often left struggling to manage boxes of pills each day. It is time for a smarter, more personal approach.
In this episode, you will hear how innovators around the world are reimagining what medicine can be. Dr. Alvaro Goyanes, CEO and Co-Founder of FABRX, explains how his team launched the world’s first clinical application of 3D printed drugs in 2018, paving the way for personalized dosing. From Singapore, Dr. Seng Han Lim, Co-Founder and COO of Craft Health, describes how their heat-free printing technology protects fragile biologics that traditional methods destroy. And in Finland, Dr. Niklas Sandler, Founder and CTO of CurifyLabs, shows how they are bringing 3D printing directly into pharmacies with compact printers and cartridge systems, giving pharmacists the ability to produce safe, customized medicines on demand. To ensure these advances are reliable and widely adopted, Dr. Thomas Forbes of the NIST shares how the institute is building essential measurement standards for printed pharmaceuticals.
From shrinking the pill burden for tuberculosis patients to tailoring cancer treatments for individuals, the breakthroughs are already here. The possibilities are just as striking looking ahead. Just think of on-demand medicines in disaster zones, or astronauts printing personalized therapies on long space missions.
This conversation offers a front-row seat to the future of medicine, whether you are a healthcare professional, technologist, or patient advocate. Tune in as we explore how 3D printing is not only changing the way drugs are made, but also redefining what medicine can mean.
Watch on demand: https://3dheals.com/courses/3d-printed-pharmaceuticals/
Event highlight shownotes
Youtube highlights
Send us a text
Support the show
Subscribe to our premium version and support the show.
Follow us:
Twitter
Instagram
Linkedin
3DHEALS Website
Facebook
Facebook Group
Youtube channel
About Pitch3D
Lee Dockstader takes us on a fascinating journey through the commercialization of 3D printing in healthcare, drawing from his decades of experience with industry giants like HP and 3D Systems. Dockstader is one of the major pioneers of the 3D printing revolution that helped transform medical applications today.
The conversation takes us behind the curtain of industry-defining moments few people know about. One is the story of Invisalign. Today it’s a household name, but in its early years Align Technology struggled to survive. Orthodontists resisted the innovation, and for nearly a decade the company failed to turn a profit. It was only when dentists began to embrace the technology that it found its footing. We explore why some healthcare segments adopt 3D printing rapidly while others move at glacial pace, and the fascinating business dynamics that determine success beyond just having superior technology.
Dockstader then goes on to give his account of the hearing aid industry's rapid transformation. Unlike dental's decades-long evolution, hearing aid manufacturing converted entirely to 3D printing within just five years in the early 2000s. The perfect storm of new scanning technology, specialized resins, and advanced printers led to dramatic improvements: reducing remake rates from 20% to 5% and transforming a craft that took a year to master into a skill learnable in days. With five companies controlling 80% of the market, once one adopted the technology, competitors had no choice but follow.
Looking toward the future, Dockstader shares his surprise that 3D printed eyewear hasn't yet achieved mainstream adoption despite its obvious benefits. With conventional frames offering limited sizing options despite high tooling costs, 3D printing could provide perfectly fitted frames for diverse facial structures at competitive prices.
As he looks back on his career, Lee Dockstader leaves listeners with a clear message. Persistence pays off, and finding the right champions within an industry can be the key to turning groundbreaking ideas into world-changing realities.
Stay tuned for show notes with relevant links and resources.
Sound Engineer: Faith Fernandes
Send us a text
Support the show
Subscribe to our premium version and support the show.
Follow us:
Twitter
Instagram
Linkedin
3DHEALS Website
Facebook
Facebook Group
Youtube channel
About Pitch3D
The future of medicine is growing closer to recreating the very building blocks of life itself. In this groundbreaking discussion, four bioprinting experts reveal how their technologies are moving rapidly from laboratory concepts to clinical realities that could forever change how we treat disease.
Mike Graffeo, the CEO and co-founder of FluidForm Bio, shares the group's remarkable progress toward eliminating insulin injections for type 1 diabetes patients. Their FRESH 3D bioprinting technology creates implants that produce insulin naturally in response to blood glucose. "Life should not come with a needle," Graffeo emphasizes, highlighting how their approach could deliver a functional cure.
Other leaders in bioprinting go on to share their unqiue approaches to 3D innovation in medicine. Annaliese Vojnich, Business Development and Technical Sales Manager at ViscoTec America, demonstrates how Puredyne's progressive cavity pump technology achieves precise extrusion while maintaining cell viability.
Dr. Jorge Madrid-Wolff, Application Scientist, reveals Readily3D's volumetric printing, which creates complex structures in seconds rather than hours, enabling functional mammary gland models that produce milk proteins and beating cardiac tissue. Dr. Karolina Valente, Founder and CEO, explains how VoxCell BioInnovation's vascularized tissue models are addressing the 95% failure rate of oncology drugs in clinical trials by providing more translatable data than animal testing.
Ready to witness firsthand how bioprinting is transforming from science fiction into medical reality? This discussion provides both the scientific foundations and practical pathways that will bring these revolutionary technologies from laboratory benches to hospital bedsides within the next decade.
Sound Engineer: Faith Fernandes
Event On-Demand
Send us a text
Support the show
Subscribe to our premium version and support the show.
Follow us:
Twitter
Instagram
Linkedin
3DHEALS Website
Facebook
Facebook Group
Youtube channel
About Pitch3D
What happens when cutting-edge technology meets veterinary expertise? Precision, innovation, and better outcomes for our four-legged family members.
Dr. Bill Oxley, a prominent figure in veterinary orthopaedics, walks us through the evolving world of 3D-guided veterinary surgery. With years of surgical experience behind him, Dr. Oxley began to question the limits of traditional planning methods. Complex bone deformities that looked manageable on initially often became challenges in the operating room. The tools weren’t the problem. The planning was. His solution? Bringing veterinary orthopedics into the three-dimensional world through advanced imaging, computer-aided design, and 3D printing.
Dr. Oxley's approach helped 3D planning completely change how we asses deformities for the better. The shift from struggling with conventional 2D planning to creating precise surgical guides. These custom guides allow surgeons to make exactly the right cuts in exactly the right places, dramatically improving outcomes for patients with complex orthopedic conditions. The emotional highlight comes when he shares the story of a Great Dane with bone cancer who, thanks to this technology, went from facing amputation to running joyfully on the beach just weeks after reconstructive surgery.
Beyond the technical aspects, we explore the business challenges of building Vet3D, the global adoption of these techniques, and how pet insurance dramatically impacts which animals can access these life-changing procedures. For pet owners, this conversation offers invaluable insights into what's possible when your beloved companion faces orthopedic challenges.
Curious about the cutting edge of veterinary care? Want to understand how technology is expanding what's possible for our pets? This episode will leave you amazed at how far veterinary medicine has come and hopeful about where it's heading. Connect with Dr. Bill directly at bill@vet3d.co.uk to learn more about these groundbreaking approaches.
Show notes, photo gallery, resource links: Please see our show notes here.
Sound Engineer: Faith Fernandes
Send us a text
Support the show
Subscribe to our premium version and support the show.
Follow us:
Twitter
Instagram
Linkedin
3DHEALS Website
Facebook
Facebook Group
Youtube channel
About Pitch3D
This is an AI-generated audio version of the news section of the Lattice Newsletter. You can find the full newsletter, including a list of recent healthcare 3D printing and bioprinting news here.
Full Lattice Newsletter Archive.
Highlighted news this week:
• US Army developing field-deployable bioprinting labs for creating custom skin grafts in combat zones
• Stanford researchers designing organ-scale vascular trees for 3D-printed hearts 200 times faster than previous methods
• First patient treated with a bioengineered external liver (ELAP) for acute liver failure
• Researchers creating 3D bioprinted brain models that mimic real neural networks for studying Alzheimer's
• FDA-cleared monolithic full-color 3D printed dentures (Trudent) revolutionizing dental prosthetics
• New polymer blend for 3D printed medical devices kills 99.99999% of common bacteria
• World's first 3D-printed femur transplant in an 8-year-old child in Vietnam
• Healthcare systems bringing 3D printing capabilities directly into hospitals for point-of-care manufacturing
• Six key trends: hyper-personalization, point-of-care manufacturing, advanced materials, increased efficiency, addressing healthcare challenges, and regulatory progress
Send us a text
Support the show
Subscribe to our premium version and support the show.
Follow us:
Twitter
Instagram
Linkedin
3DHEALS Website
Facebook
Facebook Group
Youtube channel
About Pitch3D
Artificial intelligence is transforming medical 3D printing and bioprinting. In this virtual event, hear from a panel of experts from across the globe. Our speakers showcase the practical applications of AI in creating personalized medical solutions that were previously impossible.
One size does not fit all. William Jung, Business Development Director of FITme in South Korea, explains how AI-driven customized silicone implants are revolutionizing cosmetic and reconstructive surgery. Using a design screening engine that reduces design time from hours to minutes, FITme’s technology has supported over 30,000 surgical cases and captured 85% of the Korean market.
At the National University of Singapore, Dr. Gopu Sriram explores dental applications of 3D bioprinting. He discusses how an AI-optimized bioprinting process allow for the biofabrication of personalized gum tissue constructs. Gum disease is a worldwide public health burden that affects almost half adults over age thirty. This solution not only addresses these patients, but dramatically accelerates experimental timelines.
Dr. Gregory Hayes brings in the business perspective and shares how EOS Additive Minds is implementing AI across multiple fronts to democratize access to additive manufacturing. Their systems incorporate advanced monitoring tools capable of making real-time adjustments during printing. This allows medical professionals to stay focused on patient outcomes over technical issues.
Focusing on women's health, Aye Nyein San from Cosm Medical shared how their AI-powered digital gynecologic devices are giving women their lives back, with patients describing their products as "magical" and "life-changing."
What makes this event so compelling to listen to is how our speakers illustrate AI’s ability to break down long-standing barriers to 3D printing adoption. By automating complex design decisions and enhancing process reliability, AI is turning specialized, expertise-heavy workflows into scalable, patient-centered solutions.
Ready to explore how AI and 3D printing could effect your medical practice or research? Subscribe to our podcast for more insights into this rapidly evolving field, and join our community of innovators.
Shownotes: https://3dheals.com/event-recap-artificial-intelligence-updates-for-3d-printing-and-bioprinting/
Podcast En
Send us a text
Support the show
Subscribe to our premium version and support the show.
Follow us:
Twitter
Instagram
Linkedin
3DHEALS Website
Facebook
Facebook Group
Youtube channel
About Pitch3D
Printhead technology may not sound revolutionary, but what if it could radically transform the way we manufacture everything from electric motors to medical implants? That's exactly what Ben Harkoff and his team at Quantica have achieved with their breakthrough inkjet system that can handle materials 10-20 times more viscous than any conventional technology.
Starting in 2018 with a simple goal of printing electronics, Ben's team became frustrated when every existing printhead failed spectacularly when trying to eject viscous resins. Their solution? Design something completely new using piezo crystal actuators and compliant mechanisms that could amplify deformation. This innovation unlocked the ability to print materials with viscosities ranging from 250 millipascal-seconds at operating temperatures to 15,000 millipascal-seconds at room temperature, opening up vast new possibilities for manufacturing.
What's particularly fascinating is Quantica's journey from 3D printing visionaries to practical problem-solvers. As Ben candidly shares, the company discovered its most immediate impact wasn't in creating complete 3D-printed products but in revolutionizing existing manufacturing processes. Their technology now enables precision deposition of adhesives for e-motors, replacing inefficient dispensing methods and potentially improving motor efficiency. They've validated the printing of true platinum-catalyzed silicone (SYLGARD 184) without additives—a breakthrough for medical applications—and are exploring how viscoelastic materials enhance cell viability for bioprinting applications.
Whether you're interested in manufacturing technology, materials science, or how startups navigate the challenging path from invention to commercial success, this conversation offers valuable insights. Ben's advice for aspiring inventors? "Become obsessed and become an expert in research... train your attention span... and learn about politics, because part of the job is not only the technical depth but also dealing with people." Listen now to discover how printing the unprintable is creating entirely new possibilities across industries.
Complete show notes with references
Send us a text
Support the show
Subscribe to our premium version and support the show.
Follow us:
Twitter
Instagram
Linkedin
3DHEALS Website
Facebook
Facebook Group
Youtube channel
About Pitch3D
Tuan Tranpham shares his extraordinary journey from Vietnamese refugee to 3D printing industry leader, offering unique insights on industry evolution, technological innovation, and future trends. His global perspective bridges Eastern and Western manufacturing approaches while highlighting continuous carbon fiber printing opportunities and microfactory development.
- Vietnamese refugee turned global 3D printing leader
- 3D printing in 2003, after Z Corp
- The Journey: 3D Systems, Desktop Metal, Anisoprint
- Industry consolidation and integration strategies
- Carbon fiber 3D printing for aerospace and defense
- Highlights China’s rapid rise in 3D printing innovation
- AI, robotics, and AM will enable portable microfactories
- Built a personal brand on LinkedIn
- Innovation is key to staying competitive
- Bravery and generosity in career growth
Show notes
Send us a text
Support the show
Subscribe to our premium version and support the show.
Follow us:
Twitter
Instagram
Linkedin
3DHEALS Website
Facebook
Facebook Group
Youtube channel
About Pitch3D
When EOS president Glynn Fletcher declared "3D printing is cool, but cool is not a business model" at Rapid TCT 2025, he captured the evolution across the additive manufacturing landscape. In this eye-opening conversation with Craig Rosenblum, president of Himed, we explore how the industry matures beyond technological demonstrations toward practical, sustainable applications.
Craig brings a unique perspective as both a materials science expert and the leader of a 35-year-old biomaterials company (Himed) that has adapted to incorporate 3D printing into its portfolio. He walks us through the shifts he observed at North America's largest 3D printing conference, where the atmosphere has noticeably changed from previous years' technology showcases to focused discussions on industry-specific solutions.
The conversation reveals fascinating developments, from the MIT startup creating "gravity-defying" materials through Rapid Liquid Printing in hydrogels to the reality behind AI buzzwords in additive manufacturing. We discuss how the ecosystem surrounding 3D printing is expanding, with increased participation from supporting industries like materials suppliers and testing laboratories, who recognize their crucial role in advancing the technology.
Perhaps most compelling is the emphasis on collaboration over competition. As Stratasys CEO Yoav Zeif noted, "The competition is status quo" - a recognition that advancing additive manufacturing requires collective effort across sectors rather than siloed approaches. This collaborative mindset particularly resonates in healthcare applications, where improved patient outcomes provide a powerful shared purpose.
Whether you're a 3D printing professional, healthcare innovator, or curious about how manufacturing is evolving, this conversation offers valuable insights into an industry at an inflection point - moving from what's possible to what's useful, from technological spectacle to sustainable transformation.
Send us a text
Support the show
Subscribe to our premium version and support the show.
Follow us:
Twitter
Instagram
Linkedin
3DHEALS Website
Facebook
Facebook Group
Youtube channel
About Pitch3D
Peering into the microscopic world of fluid channels just got a revolutionary upgrade. At this 3DHEALS event, we explore the transformative impact of 3D printing on microfluidic device development with industry experts and researchers at the cutting edge of this technology convergence. Our speakers share how specialized 3D printing systems are overcoming traditional fabrication limitations, enabling rapid prototyping and the creation of revolutionary new designs.
Summary:
- Hamdeep Patel from CatWorks3D discusses a specialized 3D printing system optimized for microfluidics with unbeatable feature resolution.
- CatWorks3D’s CytoClear material achieves 90% cell viability with optical transparency for direct microscopic analysis.s
- Paul Marshall from RapidFluidics provides rapid microfluidic prototyping services for researchers and companies worldwide.
- Professor Christopher Moraes from McGill University utilizes 3D-printed parts combined with biocompatible materials for advanced organoid culture applications.
- Jeff Schultz from Phase AM is developing technology to directly 3D print PDMS (Silgard 184) without modifications.
- Key adoption factors include leveraging 3D printing's unique capabilities rather than replicating 2D designs.
- The integration of world-to-chip interfaces, such as Luer locks, significantly improves device reliability.
- Creating truly 3D structures with complex internal geometries represents the future of microfluidics.
The consensus is clear: successful adoption requires leveraging 3D printing's unique capabilities rather than simply replicating 2D designs. As these technologies mature, we are witnessing the emergence of truly three-dimensional microfluidic systems with integrated functionality that promises to revolutionize diagnostics, drug development, and biological research.
SUBSCRIBE to join us at future 3DHEALS conferences to connect with innovators and investors in the rapidly evolving field of 3D printing for healthcare applications.
Watch this event recording on demand.
YouTube Event Highlight Playlist.
Podcast engineer: Faith Fernandes
Send us a text
Support the show
Subscribe to our premium version and support the show.
Follow us:
Twitter
Instagram
Linkedin
3DHEALS Website
Facebook
Facebook Group
Youtube channel
About Pitch3D
Sam Onukuri takes us through his remarkable 30-year journey at Johnson & Johnson, where he transformed the landscape of medical devices through pioneering work in 3D printing technology. As a material scientist who led the development of J&J's Center of Excellence for additive manufacturing, Sam offers rare insights into how a global healthcare giant approached innovation and personalized medicine.
The conversation reveals the fascinating evolution of medical 3D printing from basic prototyping to FDA-approved implants. Sam shares the story behind breakthrough products, such as the TrueMatch graft cage – a PCL-based, bioabsorbable scaffold for bone reconstruction that has dramatically improved patient outcomes. His candid assessment of where personalization succeeds (craniomaxillofacial implants) and where it falls short (knee replacements) provides a nuanced perspective rarely found in technology discussions.
We examine the unexpected challenges that have shaped the industry, including the complex regulatory landscape, the emergence of surgical robots, and the economic realities that have tempered some early expectations. Sam's firsthand experience with point-of-care printing initiatives and customized surgical instruments provides valuable lessons about striking a balance between innovation and practicality in healthcare settings.
Looking toward the future, Sam identifies promising frontiers, including bioprinting, advancements in materials science, and the integration of AI with 3D printing technologies. For students and professionals considering careers in this field, he emphasizes the importance of strong engineering fundamentals and experiencing both startup and corporate environments to develop a comprehensive skill set.
Whether you're a healthcare professional, engineer, investor, or simply curious about how medical innovation occurs, this conversation offers an authentic glimpse into the triumphs, setbacks, and unrealized dreams that continue to shape the future of personalized medicine and additive manufacturing.
Send us a text
Support the show
Subscribe to our premium version and support the show.
Follow us:
Twitter
Instagram
Linkedin
3DHEALS Website
Facebook
Facebook Group
Youtube channel
About Pitch3D
3DHEALS kicked off its first in-person/hybrid event in 2025 in San Francisco, welcoming investors, entrepreneurs, and innovators in the space. The healthcare industry is transforming, driven by 3D printing and bioprinting technologies redefining patient care. This exclusive in-person hybrid event offered an opportunity to explore the latest advancements in custom prosthetics, implants, bioprinted tissues, and scaffolds. The remarkable convergence of 3D printing and healthcare transforms medicine through customized solutions that weren't possible a decade ago. This episode brings together five leaders in the healthcare field who are harnessing additive manufacturing to solve real clinical problems and improve patient outcomes.
Summary:
- 3D-printed spinal implants have evolved from simple titanium cages to sophisticated expandable devices that restore alignment and relieve nerve compression
- Patient-specific radiation shields protect healthy tissue during cancer treatment, reducing devastating side effects like oral mucositis
- Bioprinted organoids are creating human-derived testing platforms for drug discovery
- 3D-printed trabecular metal structures are providing better bone integration for joint replacements
- AR/VR integration with 3D printing is a robust tool for surgical planning, training, and patient education..
- Evidence-based innovation remains critical, focusing on validated clinical problems rather than technology for technology's sake.
- The shift toward ambulatory surgical centers drives demand for minimally invasive solutions that 3D printing can uniquely deliver.
- Investment in medical 3D printing continues as clinical applications expand.
The experts emphasize that successful innovation must be evidence-based, addressing validated clinical problems rather than pursuing complexity for its own sake. The speakers agreed, "Just because it's complex doesn't mean it's better." This wisdom encapsulates the mindful approach needed as we continue exploring the vast potential of 3D printing in healthcare.
SUBSCRIBE to join us at future 3DHEALS conferences to connect with innovators and investors in the rapidly evolving field of 3D printing for healthcare applications.
Watch this event recording on demand.
Check out our blog for an in-depth analysis of the event!
Youtube Event Highlight Playlist.
Send us a text
Support the show
Subscribe to our premium version and support the show.
Follow us:
Twitter
Instagram
Linkedin
3DHEALS Website
Facebook
Facebook Group
Youtube channel
About Pitch3D
Jenny and Matthew discussed the latest trends and innovations in the orthopedic and medical device industry, including regenerative medicine approaches for joint and spine conditions, new technologies like 3D printing and wireless endoscopes, and workflow management solutions to improve hospital efficiency after Matthew's recent blog about his AAOS 2025 experiences. They highlighted exciting startups like Genix, Osteal Therapeutics, and Ospitek that are disrupting traditional treatment paradigms. Matthew also shared his insights on the changing landscape of industry conferences and the potential impact of politics and regulation on medical innovation. Overall, the conversation covered a wide range of cutting-edge developments that could significantly improve patient outcomes and transform the future of orthopedics.
Introductions and background
Jenny and Matthew introduce themselves and provide background on their respective roles and businesses.
Trends at recent industry conferences
Matthew shares his observations from attending recent industry conferences like the Canaccord Genuity and AAOS events. He notes trends around decreasing surgeon attendance at the larger conferences, and increased interest in regenerative medicine and solutions for prosthetic joint infections (PJI).
Regenerative medicine innovations
Matthew highlights two promising regenerative medicine companies - DiscGenics, Osteal Therapeutics, which has an implantable pain relief solution. He discusses the potential for these innovations to disrupt traditional spine surgery
Advancements in surgical tools and workflow
Matthew discusses new technologies like wireless endoscopes from companies like Lazurite and single-use endoscopes from Pristine Surgical that are improving surgical visualization and sterility. He also highlights Ospitek, a company using real-time patient tracking to optimize hospital workflow and efficiency.
Potential impact of political changes
Matthew shares his perspective on how the new Trump administration may impact medical device companies.
Recap and future outlook
Jenny and Matthew conclude by discussing the dynamic and evolving nature of the medtech industry, and the importance of remaining optimistic about the potential for innovation to improve patient outcomes, despite political and economic uncertainties.
Send us a text
Support the show
Subscribe to our premium version and support the show.
Follow us:
Twitter
Instagram
Linkedin
3DHEALS Website
Facebook
Facebook Group
Youtube channel
About Pitch3D
Learn how 3D printing technology is revolutionizing veterinary medicine with applications from orthopedic correction guides to custom-made titanium implants for cancer patients.
• 3D printing allows unprecedented precision in complex veterinary surgeries
• Orthopedic surgical guides can correct deformities within two degrees of accuracy
• Custom implants enable limb-sparing procedures for bone cancer patients
• Neurosurgical applications make pedicle screw placement safer for spinal fixation
• Maxillofacial reconstruction with 3D printed implants offers solutions for trauma and cancer cases
• Manufacturing standards remain a concern as veterinary implants lack human-grade regulations
• Technology has evolved from simple models to complex guide systems in less than a decade
• Educational models with bone-like properties are enhancing surgical training
• Proper CT imaging techniques are crucial for successful 3D model creation
• Collaboration between surgeons and engineers produces the best outcomes
Join us on this journey through cutting-edge veterinary medicine and see how this technology could benefit your practice or pet.
Full video recording is now available at 3DHEALS.COM/Courses
Send us a text
Support the show
Subscribe to our premium version and support the show.
Follow us:
Twitter
Instagram
Linkedin
3DHEALS Website
Facebook
Facebook Group
Youtube channel
About Pitch3D
We examine the pivotal role of 3D printing technology in reshaping orthopedic implants and enhancing patient outcomes in this virtual event. This discussion navigates the crossroads of innovation and caregiving in modern medicine by featuring expert insights from industry leaders.
• Focus on patient-specific implants and their clinical implications
• Discussion on biocompatible materials and new technologies
• Regulatory landscape for 3D-printed orthopedic devices
• Insights on surgical practices and patient recovery trends
• The benefits of personalization in surgical interventions
• Investigations into osseointegration and design efficacy
• Evolving market dynamics and future trends in 3D printing
Listen to this virtual event recording, a thought-provoking exploration of 3D printing's revolution in healthcare and the impact of innovation in the orthopedic space!
Full on-demand recording: https://3dheals.com/courses/3d-printed-devices-in-orthopedics/
Send us a text
Support the show
Subscribe to our premium version and support the show.
Follow us:
Twitter
Instagram
Linkedin
3DHEALS Website
Facebook
Facebook Group
Youtube channel
About Pitch3D
Discover FRESH 3D bioprinting with Mike Graffio, CEO and co-founder of Fluoform3D. Having met at Carnegie Mellon University, Mike and Adam Feinberg have been on a mission to revolutionize the field of bioprinting, focusing on creating replacement tissues and organs without introducing foreign substances into the body. Mike shares the captivating journey from their engineering days in the 1990s through a pivotal 2015 conversation that transformed their research into a thriving startup and onto achieving significant milestones like developing living cardiac tissues and heart valves by 2018.
Our conversation uncovers the next frontier in 3D bioprinting, particularly the promising strides in islet cell replacement therapy for diabetes. You'll hear about how the FRESH bioprinitng propels this innovative field forward. With breakthroughs in small animal models showing potential for diabetes management, we explore how the team is gearing up for more extensive studies and human clinical trials. This episode also delves into their strategic fundraising efforts and partnerships to bring these advancements to life.
Summary:
• Overview of Fluoform3D and its founding story
• Explanation of FRESH Technology and its significance in bioprinting
• Current progress in cardiac applications and in vitro tissues
• Ongoing projects related to therapeutic applications for type I diabetes
• Insights into navigating funding and building investor relationships
• Discussion on regulatory pathways and interactions with the FDA
• Emphasis on company culture and team dynamics
• Recommendations for industry insights and staying informed about bioprinting trends
Show Notes:
Instagram interview with Mike in 2021
Fluidform3D website
Breakthrough publication in 2019 made it to the cover of Science magazine-"FRESH 3D Printing Used to Rebuild Functional Components of the Human Heart"
YouTube Video: https://youtu.be/BJbReV0v7Co
Send us a text
Support the show
Subscribe to our premium version and support the show.
Follow us:
Twitter
Instagram
Linkedin
3DHEALS Website
Facebook
Facebook Group
Youtube channel
About Pitch3D
Our panel of investors at the 3DHEALS Pitch3D Demo Day 2025 provide 3D printing startups and entrepreneurs advice and opportunities as they start their journey in MedTech.
Nicole Black, PhD (https://www.linkedin.com/in/nicole-black-phd/) is the Program Director for MedTech Innovator, a nonprofit supporting early-stage and mid-stage medical device and diagnostics startups.
Peter Mercelis (https://www.linkedin.com/in/peter-mercelis-1624358/) is a medical device and 3D printing entrepreneur who has been active in 3D printing industry since 2003.
Dr. Jesse Courtier (https://www.linkedin.com/in/jesse-courtiermd/) is Chief of Pediatric Radiology at UCSF Benioff Children’s -San Francisco, Founder of Sira Medical, a venture backed UCSF spinout in the Augmented Reality space, and serves as an advisor to a number of accelerators and VC firms including KidsX and Avon River Ventures.
Full recordings are now on Youtube channel:
Pitch3D Playlist
Event page
Follow us:
Twitter: https://twitter.com/3dheals
Instagram: https://www.instagram.com/3dheals/
Linkedin: https://linkedin.com/company/3dheals
Website: https://3dheals.com/
Facebook: https://www.facebook.com/3dheals
Facebook Group: https://www.facebook.com/groups/3dheals
Youtube channel: https://www.youtube.com/@3DHEALSINNOVATION
Zoom Event Hub: https://events.zoom.us/eo/AlL-M67naa7tQL4IqXOUHjljQZI9kYu247SaGoDm-MNCWD9BuFYc~AggLXsr32QYFjq8BlYLZ5I06Dg
About Pitch3D:
https://3dheals.com/pitch3d/
medical3dprinting #medtech #bioimpression #surgicalplanning #ARVR #3DTechnology #anatomicalmodels #implants #digitalhealth #healthcare #biotech #bioprinting #bioprinter #tissueengineering #regenerativemedicine #biomedical #bioartificial #bioengineering #pharma #dental3dprinting #dentallaboratory #digitaldentistry #dentistry #digitaldentures
Send us a text
Support the show
Subscribe to our premium version and support the show.
Follow us:
Twitter
Instagram
Linkedin
3DHEALS Website
Facebook
Facebook Group
Youtube channel
About Pitch3D
This Saturday, I had a pleasant visit from the CEO and co-founder of BellaSeno, Dr. Mohit Chayya, a startup located in Leipzig, Germany, working on 3D-printed implants for both soft tissues and bone. We had some nice green tea and pastries and chatted about a slew of things from his worldly experiences from residing in four countries and Game of Thrones and the joy of reading. However, more importantly, we chatted about his company, technologies, vision and ambition, and a little military strategy and history. Enjoy!
Written interview here
Book suggestion: Alexander the Great and the Logistics of the Macedonian Army
Support the Show.
Follow us:
Twitter: https://twitter.com/3dheals
Instagram: https://www.instagram.com/3dheals/
Linkedin: https://linkedin.com/company/3dheals
Website: https://3dheals.com/
Facebook: https://www.facebook.com/3dheals
Facebook Group: https://www.facebook.com/groups/3dheals
Youtube channel: https://www.youtube.com/@3DHEALSINNOVATION
About Pitch3D:
https://3dheals.com/pitch3d/
Join a group of passionate international experts to learn about innovative biomaterials, the changing regulatory landscape, and what we can learn from failed 3D-printed implants. Please register now to be part of this inspiring conversation that promises to reshape how we think about orthopedic care.
Here we answer some "burning questions":
1. Why is 3D printing important in the orthopedic implant industry?
2. What is the most likely future trend in metamaterial?
3. How much does implant lattice design matter in optimizing bone growth?
4. How to navigate the regulatory pathway of a new 3D printed implant?
5. What is the future of 3D-printed bioceramic implants?
And much more.
https://3dheals.com/courses/3d-printed-orthopedics-implants/
Brian's slides: https://3dheals.com/wp-content/uploads/2024/08/8-1-24-SiNAPTIC-and-3DHEALS-Podcast_Scheer-v3-1.pdf
Support the Show.
Follow us:
Twitter: https://twitter.com/3dheals
Instagram: https://www.instagram.com/3dheals/
Linkedin: https://linkedin.com/company/3dheals
Website: https://3dheals.com/
Facebook: https://www.facebook.com/3dheals
Facebook Group: https://www.facebook.com/groups/3dheals
Youtube channel: https://www.youtube.com/@3DHEALSINNOVATION
About Pitch3D:
https://3dheals.com/pitch3d/
Perhaps one of the most important topics in the 3D printing industry right now.
Led by clinical and technical experts from major institutions in the US, EU, and Singapore, this event aims to update all stakeholders on everything about point-of-care 3D printing. From personalized surgical tools to anatomical models for preoperative planning, participants will discover how this technology is revolutionizing patient care by bringing manufacturing capabilities directly to the bedside. Speakers and the audience will join a conversation on the current status and future direction of this new way of care delivery.
https://3dheals.com/3d-printing-at-the-point-of-care/
Support the Show.
Follow us:
Twitter: https://twitter.com/3dheals
Instagram: https://www.instagram.com/3dheals/
Linkedin: https://linkedin.com/company/3dheals
Website: https://3dheals.com/
Facebook: https://www.facebook.com/3dheals
Facebook Group: https://www.facebook.com/groups/3dheals
Youtube channel: https://www.youtube.com/@3DHEALSINNOVATION
About Pitch3D:
https://3dheals.com/pitch3d/
This virtual event centered on biofabrication and bioprinting of musculoskeletal tissue. As the demand for effective treatments for bone and cartilage defects continues to rise with an aging population, this event is a vital platform for deep conversations about the challenges, progress, and future of tissue engineering for regenerative purposes in treating orthopedic diseases. By attending, participants will gain invaluable insights into the cutting-edge technologies and methodologies driving the development of innovative treatments for musculoskeletal diseases. Throughout the event, attendees will have the chance to engage with leading experts in the field, who will share their expertise and firsthand experiences in both the scientific and commercialization aspects of the field. Moreover, the virtual format ensures accessibility to a global audience, fostering collaboration and knowledge exchange among professionals from diverse backgrounds and regions. Don’t miss your chance to be part of this transformative event shaping the future of musculoskeletal tissue engineering and regenerative medicine.
On Demand Recording: https://3dheals.com/courses/3d-bioprinting-biofabrication-for-musculoskeletal-tissues/
Support the Show.
Follow us:
Twitter: https://twitter.com/3dheals
Instagram: https://www.instagram.com/3dheals/
Linkedin: https://linkedin.com/company/3dheals
Website: https://3dheals.com/
Facebook: https://www.facebook.com/3dheals
Facebook Group: https://www.facebook.com/groups/3dheals
Youtube channel: https://www.youtube.com/@3DHEALSINNOVATION
About Pitch3D:
https://3dheals.com/pitch3d/
This is the recording for our recent dental 3D printing event.
Since 2017, dental 3D printing has been an essential focus for the 3D printing world. The dream scenario of every dental practice having a “chair-side” mini factory is still the end goal. But like every other vertical, transforming dentistry is nuanced. From a lack of biocompatible materials to impractically expensive capital requirements, this dream has yet to be realized. However, as an industry observer, we are witnessing slow but steady progress. As Dr. Johnson, one of our speakers, mentioned in his interview, this reality is closer now than ever, with improvements taking place in every aspect of this transformation. Almost every newsletter we published would include one or two new dental 3D printing materials. From a clinical perspective, Every dental specialty (endodontists, implantologists, prosthodontists, orthodontists, etc) has participated in at least one 3DHEALS dental event. Some even have their startups. The willingness to innovate and change is evident.
At this event, the central concept of “automation” will be the focus. While many tech giants are investing heavily in LLMs (large language models), the investment in “other” branches of AI/ML is often overlooked and probably equally critical. We have more than one speaker who will speak on the subject. The end goal is 10x or 100x productivity, quality, and accessibility to dental care. As I have written in our Dental Guide, many Americans live edentulous lives. Join this free live event, be part of the conversation, and be part of the change.
Event speaker bios:
https://3dheals.com/dental-3d-printing-whats-new/
Youtube excerpts:
On-demand course:
Support the Show.
Follow us:
Twitter: https://twitter.com/3dheals
Instagram: https://www.instagram.com/3dheals/
Linkedin: https://linkedin.com/company/3dheals
Website: https://3dheals.com/
Facebook: https://www.facebook.com/3dheals
Facebook Group: https://www.facebook.com/groups/3dheals
Youtube channel: https://www.youtube.com/@3DHEALSINNOVATION
About Pitch3D:
https://3dheals.com/pitch3d/
In-silico simulation refers to using computer modeling and simulations to predict the behavior of biological systems or processes. It is an increasingly important concept for future medical device and drug development. The benefits of in-silico simulation include lowering costs, reducing animal testing, improving accuracy and safety, and clarifying regulatory pathways. This virtual event aims to illuminate the revolutionary potential of in silico simulation in not only 3D printed devices but also medical technology in general and biopharmaceuticals, led by field experts and thought leaders. From drug discovery to medical device design, participants will gain exclusive insights into how computational modeling and simulation reshape the landscape of healthcare innovation. Witness how virtual prototyping and predictive modeling accelerate novel therapies’ development and optimize treatment strategies. This is an event you must not miss.
Youtube excerpts:
https://www.youtube.com/channel/UCBNB6Q3sGmmD7ywng-1dovg
On-Demand Recording:
https://3dheals.com/courses/in-silico-simulation-for-medtech-and-biopharma/
Support the Show.
webinar upload outtro
Support the Show.
Relevant links:
3dprinted basketball by Wilson:
https://www.wilson.com/en-us/explore/basketball/airless-prototype
3dprinting for #performancesports on-demand recording link:
https://3dheals.com/courses/3d-printing-for-performance-sports/
Youtube link:
https://youtu.be/s4nJQVA66Nw
MELT electrowriting printing technology is a cutting-edge method that enables the precise fabrication of intricate structures at the micro- and nanoscale levels. This technology involves the controlled deposition of molten polymer fibers using electric fields, allowing for the creation of customized structures with high resolution and accuracy. In healthcare, MELT electrowriting has significant potential for various applications. For instance, it can be used to produce scaffolds for tissue engineering, where the precise arrangement of fibers can mimic the native tissue architecture and support cell growth and differentiation. Additionally, this technology can aid in developing drug delivery systems by creating microscale capsules or fibers capable of controlled release of therapeutic agents. Furthermore, MELT electrowriting has been explored to fabricate biosensors and diagnostic devices, offering a versatile and adaptable platform for advancing healthcare technologies.
On-Demand Video Course With 3DHEALS Certificate:
https://3dheals.com/courses/melt-electrowriting-and-or-3d-printing/
Youtube Excerpts:
https://www.youtube.com/channel/UCBNB6Q3sGmmD7ywng-1dovg
Subscribe to newsletter:
https://mailchi.mp/3dheals/signup
webinar upload outtro
Support the Show.
Relevant links:
3dprinted basketball by Wilson:
https://www.wilson.com/en-us/explore/basketball/airless-prototype
3dprinting for #performancesports on-demand recording link:
https://3dheals.com/courses/3d-printing-for-performance-sports/
Youtube link:
https://youtu.be/s4nJQVA66Nw
Dentistry seems to be the potential breakthrough industry to manifest many 3D printing enthusiasts’ dreams of mass customization, point-of-care delivery, and local manufacturing hub for dental professionals, reducing inefficiency and costs. Over the past several years, 3DHEALS has invited many different stakeholders to share their experiences, ranging from material innovation, and software development, to new clinical workflows. Applications ranging from surgical guides, implants, dentures, and night guards are among the new applications gaining increasing attention either in the startup world or the industry at large, in addition to the existing billion-dollar market of dental aligners. The collective thought is that 3D printing can do more and more in parallel to the maturation of technologies. In this 90-minute webinar, we invite experts with unique perspectives about the current status and near future of dental 3D printing, including international clinicians, startup founders, and industry veterans. For those who are interested in learning more about dental 3D printing, please make sure you read this 3DHEALS Guide before the event.
Event Link:
https://3dheals.com/additive-manufacturing-in-dentistry/
On-Demand Course Link:
https://3dheals.com/courses/
Youtube Excerpt Link:
https://youtu.be/jplToVSOj0o
Subscribe to newsletter:
https://mailchi.mp/3dheals/signup
Support the showRelevant links:
3dprinted basketball by Wilson:
https://www.wilson.com/en-us/explore/basketball/airless-prototype
3dprinting for #performancesports on-demand recording link:
https://3dheals.com/courses/3d-printing-for-performance-sports/
Youtube link:
https://youtu.be/s4nJQVA66Nw
My interview with our #newyork #community #manager Craig Rosenblum on what were some highlights on #tct2023 #medical3dprinting #dental3dprinting #biomedical #biomaterials #bioprinting at the largest 3D Printing conference in the world the TCT/RAPID 2023
Support the showRelevant links:
3dprinted basketball by Wilson:
https://www.wilson.com/en-us/explore/basketball/airless-prototype
3dprinting for #performancesports on-demand recording link:
https://3dheals.com/courses/3d-printing-for-performance-sports/
Youtube link:
https://youtu.be/s4nJQVA66Nw
**In this fun and insightful conversation with the co-founder and co-owner of Cabiomede (Instagram: @CabiomedeVet), I learned a lot more about Mateusz Pawlik, who is behind many of the incredible 3D printing veterinary products for both surgical plannings and for educational purposes. As a young entrepreneur, Mateusz shared with us his earlier failures right out of school, later, business pivots, and future outlook on healthcare 3D printing, not just for veterinary medicine but also for human medicine. We discussed many challenges facing the industry, in particular, how to encourage healthcare providers to adopt a new way of practice and thinking.
Links:
Instagram: https://www.instagram.com/tv/CUvBfRTJef4/?utm_source=ig_web_copy_link Youtube: Pending
Shownotes: https://3dheals.com/category/blog/interviews/ig-live-interview
About our guest this week:**
Mateusz Pawlik, co-owner of Cabiomede
Graduate of Biomedical Engineering at the Silesian University of Technology in Poland. He gained his experience working in international companies in the medical industry as a product engineer and continuous development manager. Co-owner of CABIOMEDE – company providing R&D services in medical engineering area and Pets Analytics – startup developing an innovative solution in the field of animal health monitoring.
Operations Manager responsible for new products and technology development – presurgical models, custom made surgical guides and implants, polymeric and metal spine and joint implants for animals. Together with CABIOMEDE team developed more than 500 patient’s cases on a basis of Computed Tomography. His biggest project was related to create veterinary surgical workshop models – full canine and feline fractures database according to AOVet classification.
Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
In this episode, we were fortunate to interview the CEO of Brinter, Tomi Kalpio, on Instagram Live to learn the birth history of Brinter, what makes Brinter differentiated from other bioprinting platforms, biotechnology entrepreneur life in Finland, Tomi’s vision for the bioprinting and regenerative medicine field, and the future of Brinter, why “collaboration” is more meaningful in 3D bioprinting either in the academia or commercial/pharma world, why is no one creating software for bioprinting?
Links:
Shownotes: https://3dheals.com/category/blog/interviews/ig-live-interview
Instagram: https://www.instagram.com/tv/CUK8Y9Vppvx/?utm_source=ig_web_copy_link
About our Guest for this Episode:
Tomi Kalpio, CEO of Brinter
An innovative leader always looking for new ways to tackle old challenges by creating solutions you did not know that you need.
Leadership and Management skills:
- Technological Competence Management; Technologically-oriented business knowledge which creates a solid ground to analyze and develop global operations and processes
- Order-to-Delivery process
Technical skills:
- Bioprinting / Additive Manufacturing / 3D-printing / 3D Design Professional
- Value-adding to production processes and product
- Know how from small product specific details to large production lines
Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
In this episode of The Lattice podcast, we had the opportunity to chat with professor Ali Khademhosseini about his career, starting when he was a chemical engineering graduate student to becoming a full professor at Harvard, bicoastal move to UCLA, three-time entrepreneur, becoming an Amazon Fellow, to finally becoming the founder and director of the Terasaki Institute, a new educational research center that also wants to build young companies. While Ali has been incredibly productive in academia, his career trajectory is clearly towards academic entrepreneurship, an exciting concept to many scientists, especially in light of the pandemic and the rise of companies like Moderna. Given his success, I dug a little deeper into his secret sauce to achieve success. Fortunately, Ali was willing to share it with everyone as well as his evolving view on what is meaningful success to him and what he envisions his next achievement milestone. Since I knew Ali from his many works on biomaterials and 3D printing, we also discussed his vision for the field.
About our Guest for this episode:
https://www.linkedin.com/in/alikmit/
Ali Khademhosseini is currently the CEO and Founding Director at the Terasaki Institute for Biomedical Innovation. Previously, he was a Professor of Bioengineering, Chemical Engineering and Radiology at the University of California-Los Angeles (UCLA). He joined UCLA as the Levi Knight Chair in November 2017 from Harvard University where he was Professor at Harvard Medical School (HMS) and faculty at the Harvard-MIT’s Division of Health Sciences and Technology (HST), Brigham and Women’s Hospital (BWH) and as well as associate faculty at the Wyss Institute for Biologically Inspired Engineering. At Harvard University, he directed the Biomaterials Innovation Research Center (BIRC) a leading initiative in making engineered biomedical materials. Dr. Khademhosseini is an Associate Editor for ACS Nano. He served as the Research Highlights editor for Lab on a Chip. He is a fellow of the American Institute of Medical and Biological Engineering (AIMBE), Biomedical Engineering Society (BMES), Royal Society of Chemistry (RSC), Biomaterials Science and Engineering (FBSE), Materials Research Society (MRS), NANOSMAT Society, and American Association for the Advancement of Science (AAAS). He is also the recipient of the Mustafa Prize ($500,000 prize) and is a member of the International Academy of Medical and Biological Engineering, Royal Society of Canada and Canadian Academy of Engineering, and National Academy of Inventors. He is an author on >650 peer-reviewed journal articles, editorials and review papers, >70 book chapters/edited books and >40 patents/patent applications. He has been cited >74,000 times and has an H-index of 139. He has made seminal contributions to modifying hydrogels and developing novel biomaterial solutions for addressing pressing problems in healthcare. He has founded 2 companies, Obsidio Medical and Bioray. He received his Ph.D. in bioengineering from MIT (2005), and MASc (2001) and BASc (1999) degrees from University of Toronto both in chemical engineering.
Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
In this episode of Instagram live, we had the pleasure to interview Jordi Tura the CEO and founder of Xkelet on his entrepreneur journey and on 3D printing immobilization orthotic devices since 2014, which started with his own broken arm. In addition to the technical aspects of Xkelet's products, we also talked about how to grow a company ground up, how to work with doctors and healthcare systems, and how to improve unit economics to increase the adaption of the technologies, among others.
How can an outsider create a product to have a product-market fit in healthcare?
What was the first version of Xkelet braces look like?
What are the three major milestones of Xkelet technical and business development?
How did Jordi's clinical collaborations contribute to the design and growth of Xkelet?
How does Xkelet leverage software design to increase unit economics and productivity?
Complimentary hardware and material development to Xkelet software platform to optimize the speed and quality of scan-to-print process.
What is the benefit of staying focused on one solution?
Relevant Links:
Shownotes with video
Youtube
Instagram
About Our Guest:
@Xkelet has been working in the 3D printing immobilization orthotic space ever since 2014. CEO and Founder Jordi has met with many challenges along his journey to bring rapid and affordable user-friendly 3D printed orthosis focusing on the software step of the workflow.
Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
In this episode, we were able to have an in-depth conversation surrounding not just Amy Karle's major artworks using 3D printing and Bioprinting, but also her personal journey as a bioartist and the meanings behind her artworks. The two works we focused on include :
1. Regenerative Reliquary, which is a bioprinted scaffold with stem cells in the shape of a hand in a bioreactor to grow bone tissue
2. Heart Evolution, which is an artistic alternative design for a "better" heart that potentially could avoid existing
Some of the questions we explored include:
What does bioprinted organ replace imply to humanity and our identities?
Who has the right to live and access the new and expensive technology that can prolong life?
Who will have access to bioprinted or 3D printed medical devices first?
What makes something beautiful (Aesthetics)?
Why is it important to make something beautiful (or not)?
What is the role of an artist in terms of aesthetics?
Why is 3D printing (especially in medicine) often perceived as beautiful?
How does an artist feel about generative design? Threatened by robots?
Youtube
Shownotes
Instagram
Blogs
About our guest:Amy Karle is an internationally award-winning bioartist whose work can be seen as artifacts of a speculative future when digital, physical, and biological systems merge. Her work opens future visions of how technology could be utilized to support and enhance humanity while making advancements towards those goals in the process.
In the process of making the artwork, Karle utilizes the technological tools in question and collaborates directly with science and technology to create a joint space for imagination, exploration, and creation. Current projects probe who we could become as a result of exponential technologies and how interventions could alter the course of our future.
Karle has exhibited in prestigious museums worldwide, including at the Smithsonian, USA; The Mori Museum, Japan; The Centre Pompidou, France; Beijing Media Arts Biennale, China; Ars Electronica, Austria; and is regularly invited to share her insights as an expert speaker and in think tanks. Karle was honored as one of “BBC’s 100 Women”, has been named one of the “Most Influential Women in 3D Printing”, and was Grand Prize Winner of the "YouFab Global Creative Award". Karle was also an Artist Diplomat through the U.S. Department of State tasked with women’s empowerment and supporting collaborations using art and technology to address social issues. The long-term goals of her work are to continue to pioneer in the art and tech field and make contributions to the advancement of society, technology, and healthcare in the process. www.amykarle.com
Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
In this fun, Instagram live we interviewed Robert Pugliese, who is the Director of Innovation Design at Thomas Jefferson University, and Jefferson Health where he co-founded the Health Design Lab, a creative space built with the purpose of merging together design-studio ethos with science-oriented discipline to foster innovation in healthcare. As usual, we started our conversation with his early career, the path to founding Health Design Lab, and how 3D printing played a role in all that. Robert's 3D printing lab does not have fancy 3D printers, and he is a firm believer that having excellent design holds the key to solutions and 3D printing is a great tool to achieve that design. We were also fortunate to have a brief virtual tour of Robert's lab and talked about a few super cool clinical cases Robert is working on at the moment.
Full show notes and video recording: Robert Pugliese: Design for Healthcare with 3DPrinting
Instagram account: @healthdesignlab
About our Guest Robert Pugliese:
Robert S. Pugliese is Director of Innovation Design at Thomas Jefferson University and Jefferson Health where he co-founded the Health Design Lab, a creative space built with the purpose of merging together design-studio ethos with science-oriented discipline to foster innovation in healthcare. As somebody who enjoys empowering future health care providers to be change makers, Robert leads programs that train students to be health design thinkers and innovators. A Doctor of Pharmacy (PharmD), Robert has spent over ten years practicing and teaching in Emergency Medicine. He believes that including both the patient and provider voice is vital to healthcare design, and he brings each of these perspectives to his work through his experience as a clinician and through his own journey coping with insulin-dependent diabetes. Robert has presented on the intersection of healthcare and design at national venues such as SXSW and Stanford Medicine X and in 2019 he was selected as a Philadelphia Business Journal 40 Under 40 honoree. Throughout the COVID-19 pandemic Robert has used his unique experience to lead critical response efforts to overcome supply chain shortfalls and respond to community needs for testing and vaccination. In his spare time, Robert produces a weekly podcast and enjoys spending time with his wife and three daughters.
Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
In this episode, I had the pleasure to chat with professor Stephanie Willerth at the University of Victoria, also the founder of Axolotl Biosciences.
Stephanie is not only an expert in bioprinting and bioinks in general, but also one of a few scientists in the world focusing on using 3D cell models on common but devastating neurological diseases such as GBM, Parkinson's Disease, and Alzheimer's Disease. We started with some basic concepts related to bioprinting, bioinks, organoids, and organ-on-a-chip, and some of the general current applications and ongoing researches. All of these technologies, however, require sophisticated bioink formulation to achieve structural and functional goals. Also, who are the major players in commercial bioprinting?
Other versions of this episode:
Website
Axolotl Biosciences
Willerth Lab
Youtube
Past blog by prof. Willerth:
3D Bioprinting Glioblastoma Models for Drug Screening3D Bioprinting Personalized Brain Tissues
About Our Guest:
Dr. Willerth holds a Canada Research Chair in Biomedical Engineering at the University of Victoria where she has dual appointments in the Department of Mechanical Engineering and the Division of Medical Sciences as an Associate Professor.
She serves as the Acting Director for the Centre for Biomedical Research at the University of Victoria and on the steering committee of the B.C. Regenerative Medicine Initiative. She also served as the President of the Canadian Biomaterials Society from 2017-2018. Her honors include being named the 2018 REACH award winner for Excellence in Undergraduate Research-inspired Teaching, a Woman of Innovation in 2017, one of the 2015 Young Innovators in Cellular and Biological Engineering, and a “Star in Global Health” by Grand Challenges Canada in 2014. She spent the Fall of 2016 on sabbatical at the Wisconsin Institute for Discovery supported by the International Collaboration on Repair Discoveries International Travel Award where she wrote her book “Engineering neural tissue using stem cells” published by Academic Press.
She completed her postdoctoral work at the University of California-Berkeley after receiving her Ph.D. in Biomedical Engineering from Washington University. Her undergraduate degrees were in Biology and Chemical Engineering from the Massachusetts Institute of Technology.
Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
I had a lot of fun chatting with this international group of young entrepreneurs out of KTH from Akira Science ( @akirascience) in Sweden. We started the conversation on how the members of the team met. Then we moved onto the biopolymers the team is working on and commercializing, including why it is important to have controllable biodegradable biocompatible and 3D printable materials. We also touched upon the potential killer applications using the Akira biopolymer, including creating a scaffold for breast cancer lobectomy patients and wound healing. We also talked about the unique innovation and entrepreneurial environment in Sweden. You can find additional resources here: https://www.akirascience.com/
Youtube
Podcast
Website link
Instagram live
About Our Guests:
Tiziana Fuoco: Chief Operating Officer
Astrid Ahlinder: Product Manager
Álvaro Morales López: Marketing Manager
Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
In this live Youtube interview, I had the pleasure of getting to the co-founders (also husband and wife) for 3D Biotechnology Solutions, Ana Millás and Pedro Massaguer. 3DBS is the first Brazilian startup that brought bioprinters to its local research institutions and market, and now it is gearing up to expand its global market including that of the United States. Some of the major talking points of this episode include Ana and Pedro's early journey as biotech cofounders in Brazil, their funding strategies, market product fit, and their strategies in dealing with the local innovation ecosystem and regulatory agencies. We also dig a little deeper on their new hybrid bio fabrication bioprinter that combines electrospinning and extrusion-based bioprinting to generate unique tissue engineering capability for its customers
Follow 3DHEALS:
https://www.instagram.com/3dheals/
https://linktr.ee/3dheals
Follow our guests:
https://www.instagram.com/3dbiotechnologysolutions/
Show Notes: https://3dheals.com/made-in-brazil-interview-with-the-co-founders-of-bioprinting-startup-3d-biotechnology-solutions
More on our Guests:
Ana Millás
As a biologist, Millás holds her PhD and Master’s degree from the Department of Materials Engineering and Bioprocesses at the School of Chemical Engineering of State University of Campinas/UNICAMP. Post-doctoral degree at School of Pharmaceutical Sciences - University of São Paulo. Ana has made part of her research in internationally renowned research centers and institutions, among them, at Cornell University in the United States and Nottingham Trent University and The Electrospinning Company in UK. She has an amazing experience in the amazon forest, also experience in the textile industry. As the R&I Director at 3D Biotechnology Solutions startup, she focused her research on the development of 3D skin in vitro models, vascularized tissues and cartilage reconstruction using the technologies of electrospinning and 3D bioprinting.
Pedro Massaguer
Business Developement, is a specialist in Strategic Business Management. He completed a Master's and Doctorate in the Science and Technology Policy program at the state University of Campinas (UNICAMP). He has experience in innovative technology-based projects, business development, and strategic planning in the area of Biotechnology. He is the CEO of 3D Biotechnology solutions and also partner of In Situ Cell Therapy and Labtermo Microbiology Consultancy.
Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
Follow 3DHEALS:
https://linktr.ee/3dheals
https://www.instagram.com/3dheals
In this Episode of 3dhealsLive, we spoke about the unique journey for Dr. Zille on how he was a hobbyist CAD designer for cars (since 17 years old) to a CMF surgeon. What was the first clinical case that inspired him to dig deeper into using 3D printing for CMF and implants? What advice does he have for clinicians and newcomers who want to venture into the world of CAD/CAM design and medical 3D printing #dental3dprinting? We have the answers here.
Video version of this podcast:
Instagram
Youtube
Podcast show notes link
About our guest:Dr. Devid Zille is a practicing dental surgeon as well as the Director of Innovation at CPMH, a Brazillian 3D printing company that focuses on maxillofacial, neurosurgery, and extremity surgeries. He is a post-graduate in Oral and Maxillofacial Surgery mainly focused on the correction of facial deformities., having been trained both in Brazil and the U.S. His expertise includes 3D modeling and design using advanced concepts like lightweight structures and topological optimization based on FEA analysis and 3D printing. He has been tinkering CAD design ever since age 17.
Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
I had a lot of fun speaking to Matteo Zanfabro (Instagram account: 3dvet.printing and playvet3d) because of many good reasons. Not only we both love what 3D printing can do for healthcare but also share a passion for medical imaging, although our clients are very different. In this episode, we talked a little about his early journey into using 3D printing for veterinary medicine, and some unique challenges in adopting 3D printing for animals. There is certainly a lot for human doctors and veterinarians to learn from each others' experiences. Of course, Dr. Zanfabro brought us a few interesting cases he has 3D printed.
Listeners can find full video recording on 3DHEALS.com: https://3dheals.com/interview-w-dr-matteo-zanfabro-3d-printing-for-animals
About our guest Dr. Matteo Zanfabro Matteo Zanfabro, a Doctor of Veterinary Medicine graduated from the University of Parma in 2017. Zanfabro is applying 3D printing to Veterinary Medicine since 2015 during his experimental thesis “The use of 3D printing in pre-operative surgical planning”. He founded a private research project named “3D Veterinary Printing” focused on the clinical application of these technologies. In 2018 he won the “MSD Community Award” for the 3D VET project. In 2019-2020 was Research Fellow at the O.U. Diagnostic Imaging (University of Parma), focusing on the technological transfer of PlayCast system (www.playcast.it) to the Veterinary Medicine field. Now he is a member of R&D at PlayVet (www.playvet.it), a new company branch that designs and produces 3D-printed made-to-measure veterinary medical devices.
Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
In this episode of Instagram Live recording, I had the pleasure to interview two young startup co-founders, Adam Hecht and Alex Tholl from @divedesignco (website: DiveDesign Studio) who created a niche for themselves in the space of 3D printed prosthesis for animals and athletes. Important topics covered in this interview (in both video and podcast formats) include: How can a young product design company effectively differentiate itself from thousands of others? What was the inflection point of Adam and Alex's success story? What were their growth strategies? What new technologies are they looking at? What projects they have taken on that could potentially transform an entire industry? And more.
About our guests for this episode:
Adam Hecht Is an industrial designer, co-founder, and head of strategic partnerships at Dive Design, an NJ-based product design and engineering firm dedicated to building industry-shaping products and brands.
Alexander Tholl is the Co-Founder of DiveDesign, a strategic Industrial Design and Development firm specializing in new tech and alternative manufacturing methods. Alex oversees business administration, strategy, and acquisition while maintaining an active role in product development and prototyping at DiveDesign.
The full speaker bio and video recordings are here.
Support our Show
Related Links:
Interview with Dr. Edyta Bula, 3D Printing for Veterinary Medicine
3D Printed Bronchoscopy Simulator for Medical and Veterinary Training
3DHEALS IG Live Recordings: 3D Printing in Veterinary Medicine with Richard Doerer
From Academia: 3D Printing for Veterinary Medicine
Robin Huizing: The Power of 3D Printing Design and Education
Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
In this episode of Instagram Live recording, I invited Dr. Daniel Vegh, a young faculty member and prosthodontist from Semmelweis University to share with us his journey of learning about 3D printing for dentistry, his recent accomplishments in the space, and his vision for its future. Dr. Vegh is the author behind @3d_printing_dentistry on Instagram.
Daniel also shared how he leveraged social media to build a community for dental 3D printing both locally and internationally. He also brought us a few examples of his past works on camera.
Additional highlights of this interview:
What is the current status of establishing a formal curriculum in dental schools?
Who is most interested in adopting 3D printing in their dental practices?
How to find other dentists who are actively using 3D printing?
What are some suggestions for new dentists to space?
Full interview recording including video recording and additional links can be found here: https://3dheals.com/learning-dental-3d-printing-through-social-media-an-interview-with-dr-daniel-vegh
Who is Dr. Daniel Vegh?
Dr. Dániel Végh DMD, Ph.D.
Specialist in Conservative Dentistry and Prosthodontics
Semmelweis University - Department of Prosthodontics - Budapest, Hungary
In his own words, " My name is Dr. Daniel Vegh! I earned my DMD degree at the Semmelweis University in 2015!
I am working at the Department of Prosthodontics since then! I am a prosthodontist since 2018, and I earned my Ph.D. Degree in 2019, the topic was diabetes and oral complications!
As a regular participant of dental congresses, I meet with 3D printing technology on-site, and I become a fanatic!
I found out that a lot of my colleagues are interested in it, but there is a lack of experience and knowledge about it! I started my Instagram page ( @3d_printing_dentistry), where my aim is to build International connections! Semmelweis University established SE3D lab, an innovative place dedicated to 3D printing for students and staff! It has research, educational and clinical aspects!"
Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
It has been almost nine months since we interviewed Mike Graffeo, CEO, and co-founder of Fluidform, a 3D printing startup out of Carnegie Mellon University focusing on key applications using Freeform Reversible Embedding of Suspended Hydrogels (FRESH) technology. If the average lifetime of a typical startup is five years, the one-year time of a startup is equivalent to 20 human years. Check out the recording of this episode of Instagram Live on how a bioprinting startup was founded, lessons learned, ambitions, and more.
The video format of this interview can be found on 3dheals.com.
Instagram Live occurs every Thursday to put the innovators, artists, and founders behind impressive 3D technology Instagram shares in front of the camera. Want to join us next Thursday? Direct message us on Instagram @3dheals.
About our guest:
Mike Graffeo
CEO and co-founder of Fluidform
A senior executive with a proven track record in the commercialization of innovative medical technology, Mike is a results-oriented, decisive leader with a track record of successfully growing new businesses in both startup and growth organizations. Throughout his career, he has gained extensive experience translating highly complex devices and clinical data into successful businesses, both in the US and globally. Mike holds a BS in Engineering Physics and an MEng in Mechanical Engineering from Cornell University, as well as an MBA from Harvard Business School.
Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
This fun and insightful conversation with Juan Pablo Garcia Venegas, the engineer behind works on Instagram @m3daid. Juan shared with us how he was inspired to create various 3D printed medical models for the simple but important goal to help the medical students and trainees to learn human anatomies better, with advantages of not recognizing three-dimensional shape but also mobility and functionality, things impossible from an anatomy book.
I could not agree more.
Here are my first several attempts in 3D printing Juan's model of a shoulder. I cannot wait to do more. We will be sharing Juan's STL files in a new 3DHEALS file-sharing portal. Stay tuned for announcements.
Video recording, notes link: https://3dheals.com/3d-printing-for-medical-students
About our Guest:
Juan Pablo Garcia Venegas
(Instagram @m3daid)
"My name is Juan Pablo García, I'm a biomedical engineer from Monterrey, Mexico. Currently, I'm an R&D Engineer at BMC Medical Manufacturing, which is a Mexican company focused on the development of medical devices. During my studies, I had the opportunity to make internships in hospitals as a clinical Engineer, as well as being involved in high-tech projects such as skeleton manufacturing and orthosis design. I think that digital manufacturing and 3D printing will change the way that medicine is being approached."
Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
What is generative art? What is algorithmicart ? What is fractal? How is this related to the world of 3D printing, bioprinting, and 3dHEALS? Join me and our guest Robert Bruce, the young artist behind some very mind-expanding art pieces using computer science and mathematics.
About our guest Bruce Roberts:
"My name is Bruce (the artist behind Instagram @canvas.51) and I am studying engineering. As a kid, I developed a passion for programming and have been doing so as a hobby ever since. Programming is how I express the beauty I see in nature and in mathematics. While I work towards my degree I am exploring my creative side through computer-generated art. I hope my work inspires and reinforces people’s appreciation for the patterns found in nature."
Full video recording link: https://3dheals.com/generative-art-and-3d-printing-a-conversation-with-bruce-roberts
Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
In this episode, we chatted with Dr. Zsuzsanna Puspokis about how she co-founded Rhino3DMedical, a medical 3D printing-focused software based on Rhino 3D. Zsusanna demonstrated a few surgical examples in this interview.
About our guest:
Dr. Zsuzsanna Puspokis
Zsuzsanna received her PhD from the Swiss Federal Institute of Technology, Lausanne (EPFL, Switzerland) in 2016, where she completed her thesis at the internationally renowned Biomedical Imaging Group (BIG) headed by Prof. Unser.
Following her doctoral studies in Biomedical Imaging and before starting her own company, Zsuzsanna worked for a year at the Lausanne University Hospital (CHUV, Switzerland) on the Human Brain Project, a flagship project of the European Union. During her employment at the hospital, she further strengthened her industry and academic links and deepened her knowledge of MRI imaging, from data acquisition to processing and analysis, in the clinical context.
Since 2017, she is a co-founder and the COO of Mirrakoi SA. The company offers software solutions (Rhino3DMedical) for orthopedic and CMF surgical planning, facilitating the creation of patient-specific 3D printable anatomical models and surgical guides from medical CT/MRI scans (https://rhino3dmedical.com/). At Mirrakoi SA, Zsuzsanna leads the design and implementation of business operations. She is responsible for marketing and sales, including PR and customer relations. Zsuzsanna is well-connected within the European start-up, venture, academia, and entrepreneurship scenes where she has been active for several years and recognized by various awards and grants.
Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
We had some technical issues with the IG live session but fortunately, we are able to salvage pearls of wisdom from Satori3DP CEO ChengXi. Here is the recording of our fun, pragmatic, and inspiring conversation about the current and future status of #dental3Dprinting #startuplife , how to make it work with new technologies (hint: not always easy or straightforward), and the importance of good customer service. As usual, there was also a live demo of fascinating 3D printed designs.
About our guest ChengXi Wang and Satori 3DP:
Graduated with MBA from the University of Oxford and certified as CFA, Chengxi is an interdisciplinary entrepreneur who develops technology products with a human-centered approach. She is leading the London-based Satori team to challenge the status quo by making high-quality professional 3D printing affordable, and push the boundary of our imagination with thoughtful 3D printed products.
The new release of Satori ST1600 3D printer focuses on solving the pain points in dentistry. It can be afforded by the dental clinics to fabricate clear aligners (the same technology used in Invisalign), surgical drill guides, orthodontic models, and other dental solutions. Dentists and patients don’t need to wait for weeks to get their work done by dental labs and can potentially get their aligners 3D printed under an hour at a production cost less than £5. In the face of supply chain disruption catalyzed by COVID and Brexit, Satori’s affordable and user-friendly professional 3D printers can adapt to the work from home environment and bring remote manufacturing localized, which empowers businesses to gain control over uncertainty and transform their performance with efficiency.
Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
Why is Copper the new darling to the 3D printing industry? Even before the pandemic, Daniel Martinez and his co-founders at Copper3D, a Chilean startup, had a grand vision for Copper-based nanocomposite materials, for 3D printing, and for non-additive manufacturing globally to produce products that have long-lasting anti-microbial products. This podcast is a recording of our weekly Instagram Live interview with Daniel. You can find the video version of this recording on our website 3dheals.com, our IG account, and our Vimeo channel.
IGTV Video
Guest Biography:
Daniel Martínez is a Chilean Healthcare professional passionate about innovation and the impact it can have on the quality of life of people. His professional career has been linked to management and marketing in healthcare organizations. In 2008 he obtained an MBA in Chile.
Then, in 2016 he started an MSc. of Innovation, which led to a profound change in his way of seeing the world.
He began to see global problems as big challenges and opportunities to generate a huge impact with creative, innovative, and disruptive solutions. A typical day of Daniel consists of a mix between academia (he is a professor of innovation in several universities in Chile) and his activities as Chief Innovation Officer at Copper3D, where he is responsible for the short term (commercial and marketing strategy) and the long term of the company working on brand positioning, new products for the portfolio, innovation architecture, new business models and strategic alliances.
Relevant articles:
https://3dheals.com/antimicrobial-materials-for-3d-printing-medical-devices
https://3dheals.com/antimicrobial-3d-printing-toys-for-immunosuppressed-children
https://3dheals.com/why-copper-a-conversation-with-daniel-martinez-copper3d-recording-and-notes
Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
We recently had the pleasure of interviewing Robin Huizing, the founder of Addmio, a 3D printing education platform. During this fun application, Robin showed us the power of design with a demo from his new idea of a personalized mouse. Our conversation expanded from there.
Who is Robin Huizing?
Robin is the founder of Addmio a 3D printing education platform. He recently also joined Oqton as its application engineer. In his own words,
“During my study, I started my own design studio, sample. studio, and ran it for more than 10 years. I created corporate identities and websites, visuals for architectural firms, and hosted creative workshops at universities.
After my graduation, I started my career as a 3D Printing Engineer at Shapeways. I worked in every production team and with every in-house technology and in a few years I learned to work with FDM, SLA, DLP, MJP, and SLS. All plastic 3D printing technologies. In total I prepared, 3D printed, and post-processed 10.000+ parts.
Then I moved to Additive Industries to work as an Additive Manufacturing Designer. Here, I specialized in Design for AM and was also involved with production planning, application development, and a lot of local and on-site training. Here I gained valuable experience with metal 3D printing, LPBF.
In 2020 I combined everything I’ve learned and my passions for technology, education, and design and I Founded Addmio. To make 3D printing accessible through education. We’re working with a young and ambitious team to create online courses that are efficient, affordable, and accessible to everyone with a smartphone. We’ve made a great start in 2020 and are planning to grow and expand in 2021 so stay tuned. ”
Relevant links:
Show notes: https://3dheals.com/robin-huizing-the-power-of-3d-printing-design-and-education
Instagram IGTV: https://www.instagram.com/tv/CLGbOY0D5kN/?utm_source=ig_web_copy_link
Addmio: https://www.addm.io/
Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
Fun conversation with Michael Peirone and Kelly Knight with technical demos and economic discussion on how #3dprinted #prosthetics can change the lives of upper Limb amputees and the world we live in.
VHP has helped over 200 amputees worldwide and this year, they aim to help more North American patients.
Michael Peirone graduated from the University of Victoria in 2016 with a B.Eng in Biomedical Engineering. During his undergraduate degree, Michael completed two internships with Victoria Hand Project (VHP) and volunteered with VHP during his in-class semesters. Upon graduating, he began working with VHP full-time as a mechanical designer. Now as Chief Operating Officer, Michael runs the day-to-day operations of the Victoria Hand Project. This includes working with the teams in the partner countries, overseeing design updates on the scoliosis braces and prosthetic arms, and fundraising.
Kelly Knights is a fourth-year biomedical engineering student at the University of Victoria who has been volunteering with the Victoria Hand Project since September 2016. Kelly completed a co-op work term with the Victoria Hand project in Fall 2018, where she assisted with the design, development, and testing of the new Force Doubler device and the Child’s Hand. Kelly has also been involved with media outreach, the creation of training documentation, and the assembly of the Victoria Hand.
Relevant links:
Victoria Hand Project
IG Live recording
https://3dheals.com/improving-the-world-with-3d-printing
https://3dheals.com/3d-printing-low-cost-prosthetic-and-orthotic-devices
Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
This is the audio recording of a recent IG Live interview with co-founder of Anatomiz3D, an Indian medical 3D printing startup focusing on a variety of medical applications using 3D printing. Anatomiz3D is also the trailblazer on delivering point of care 3D printing service in Indian hospitals. In this interview, Firoza shared with us a few fun projects she did with surgeons (video available), and also gave us a tour of her office. By the way, this was no ordinary "office". For those who want to watch the video, you can find it on our IGTV (@3dheals) or this link: https://3dheals.com/3dheals-instagram-live-medical-3d-printing-with-co-founder-of-anatomiz3d-firoza-kothari
About the Speaker:
Firoza Kothari, Co-Founder & CTO – Anatomiz3D Medtech Pvt. Ltd. – A B.Tech in Biotechnology Engineering, Firoza Kothari started her journey to provide patient-specific medical solutions and one day end the organ donation problem by creating live organs out of patients’ stem cells. With that aspiration, she gave birth to Anatomiz3D. She, along with her team, was the first to execute soft tissue models in India through Paediatric Cardiology, partial amputee prosthetic hand, first kidney tumor case in India, and the model for tongue cancer was the first in the world. Being a Co-founder and CTO of Anatomiz3D, she, along with her team, has successfully added 700 plus case studies. Her multi-disciplinary expertise prevails in converting 2D DICOM CT/MRI/Echo Scans to 3D Printed anatomical replicas, medical devices, and allied products, using various combinations of Hardware and Software, across multiple medical specializations. Anatomiz3D has played a vital role in creating the market for 3D Printing in the Medical industry in India and are pioneers for the same.
Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
This is the audio recording of a recent 3DHEALS IG Live session. We had the pleasure to interview Dr. Mayra Vasques, founder of Innov3D. She is also an educator and a passionate technologist for the adoption of dental 3D printing. In this episode, we focused on an application that inspired her journey: a 3D printed nightguard. This was also relevant to her Ph.D. thesis. We also answered live audience questions, including how the adoption of 3D printing differs between small and large dental labs. Dr. Vasques reveals some facts not commonly known to the public.
Guest Speaker Bio:Dr. Mayra Vasques is the founder of iNNOV3D an EdTech company focused on supporting and training teachers and universities in Healthcare for the innovative and efficient use of 3D Technologies. The company was founded based on the belief that the best innovative solutions in healthcare will emerge from professionals that are raised familiar with technology and for this, the institutions must be prepared for these professionals.
She started in the additive manufacturing field in 2015, during her Ph.D. Fellow at School of Dentistry at the University of Sao Paulo, where she led a project in additive manufacturing for the development of occlusal splints for patients with orofacial pain. Since then she has been involved in several AM research projects and as a panelist in conferences.
She is deeply involved in creating a positive and more accessible local ecosystem in Brazil for digital technology and AM, working for local community building associated with international organizations such as ”Women in 3D Printing” and “3DHeals”.
The video format of the show and relevant info can be found in the following link:
3DHEALS Instagram Live Recording: Dental 3D Printing with Innov3D Founder Dr. Mayra VasquesSupport the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
What is the Australian and Melbourne healthcare 3D Printing/ Bioprinting ecosystem like? Look no further than our Melbourne community manager William Harley, who not only has been keeping a close eye on local trends and happenings but also has a deep understanding of the scientific aspects of the development. In this episode, we learned a little about Bill's research on acoustic assisted bioprinting, local leaders on the commercial side of healthcare 3D printing, and major funding entities. Of course, we also highlighted the upcoming Melbourne virtual event and How he picked speakers for this event. (Free event, almost sold out.) During the live Q&A session, we talked a little about getting a Ph.D. and being a scientist.
Speaker Bios:
William Harley
William Harley graduated with honors in medical biotechnology from the University of New South Wales. Currently, he is undertaking a Ph.D. at the University of Melbourne in acoustophoretic bioprinting. Stemming from his research experience in biomaterials, stem cells, and nanofabrication, he is driven by the clinical translation of personalized regenerative medicine. He is passionate about the innovation of 3D printing in healthcare and is determined to orchestrate a series of 3D HEALS events to engage in the Australian community.
Jenny Chen, M.D.
3DHEALS Founder/CEOJenny Chen, MD, is currently the Founder and CEO of 3DHEALS, a company focusing on education and industrial research in the space of bioprinting, regenerative medicine, healthcare applications using 3D printing. With a focus on emerging healthcare technology, Jenny invests in and mentors relevant startups, especially companies pitching through Pitch3D. She believes a more decentralized and personalized healthcare delivery system will better our future.
Relevant links to this episode:
Bioprinting for Tissue Engineering and Regenerative Medicine in Australia: 2020 Workshop Highlights
Australian Regulatory Updates for 3D Printed Medical Devices and Implants
3D Med 19 Conference (Australia) Recap
Bioprinting Down Under (Australia): Recent Workshop Take-away
Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
Richard Doerer, founder of Modl3DVet, also a 25 year veteran in 3D printing shared his recent works and vision for the future veterinary 3D printing market with Jenny Chen. Ranging from anatomical surgical model, military/police dog training device, to educational tools, Richard showed us a new burgeoning market that has been accelerated since the pandemic. Many questions are still unanswered, and he highlighted the importance of the upcoming 3DHEALS March virtual event: https://3dheals.com/3d-printing-in-veterinary-practice (Registration to this live webinar is free by the way).
Other important links:
https://3dheals.com/3dheals-live (future 3DHEALS IG Live event)
https://3dheals.com/guide-together-into-2021-connected-while-decentralized (our event and media guide for 2021)
About Our Speakers:
Richard Doerer
3DHEALS Detroit Community Manager, Founder Modl3d, LLC Royal Oak, MI
Richard Doerer is the 3DHEALS Detroit Community Manager. He is the founder of Modl3D, LLC, a medical technology company specializing in 3D printing and medical imagery for veterinary practices and education. Recent projects include canine nasal sarcomas, brain meningiomas, and aneurysms in the caudal vena cava. He started with additive in the 1990’s using 3D Systems SLA’s for product development for consumer goods. Richard has been involved in product development in consumer products and automotive for the past 25 years. In addition to his work with Modl3D, Richard is the Additive Lab Manager/Engineering Manager for Adient, LLC. Adient, LLC is the largest global automotive seat manufacturer. Richard is a graduate of the Yale School of Art MFA and Michigan State University MBA.
Jenny Chen, M.D.
3DHEALS Founder/CEOJenny Chen, MD, is currently the Founder and CEO of 3DHEALS, a company focusing on education and industrial research in the space of bioprinting, regenerative medicine, healthcare applications using 3D printing. With a focus on emerging healthcare technology, Jenny invests in and mentors relevant startups, especially companies pitching through Pitch3D. She believes a more decentralized and personalized healthcare delivery system will better our future.
More about this session: https://3dheals.com/3dheals-ig-live-recordings-3d-printing-in-veterinary-medicine-with-richard-doerer
Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
This is a recording of our recent Instagram Live session with Fabio Sant’Ana, focusing on metal 3D printing implants, the importance of feedstock, and what are the major differences in applications between Electron Beam Melting (EBM) and Selective Laser Melting (SLM) 3D printer. This conversation was inspired by his recent Expert Corner blog. During the live audience Q&A, we also answered questions related to anatomical modeling both in the U.S. and Brazillian market.
Fabio Sant’Ana has a Precision Mechanics degree and a Business Administration Bachelor’s, born and raised in São Paulo he has 25 years of experience in helping companies to acquire and take full advantage of 3d Machining and Additive Manufacturing Equipment. Entrepreneur and knowledge avid is a member of standards organizations ASTM F42 Additive Manufacturing, ABNT CEE-261 Manufatura Aditiva e ABNT CB-26 Odonto-Médico-Hospitalar. CAD/CAM, Surface Modelling, and EBM specialist is passionate in connect people and companies to the right tools to accomplish the mission. You can follow Fabio on Instagram @farccotecnologia.
https://3dheals.com/metal-3d-printing-implants-with-fabio-santana-instagram-live-recording-show-notes
Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
A fun but insightful conversation during 3DHEALS2020 with two inspiring entrepreneurs in 3D Bioprinting space, Tamer Mohamed (CEO and co-founder of Aspect Biosystems), and Mike Graffeo (CEO and co-founder of Fluidform). Aspect bio has just successfully completed its series A round, and Fluidform just successfully raised its seed round. Learn from Tamer and Mike on what startup CEOs' challenges, experiences, visions, and advice for the biofabrication and 3D printing space.
Full conference video recording can be purchased here.
Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
Allevi (previously known as Biobots) was one of the earliest companies focusing on bioprinting for pharma research and organ regeneration. We are fortunate to have a fun and insightful 20-minute ice breaker style interview with its co-founder and CEO Ricky Solorzano, starting from how Ricky got introduced into the RepRap movement, how he crossed paths with several great minds in the field throughout his scientific and entrepreneurship journey, where Allevi is as a company, and how he and his team is coping with the pandemic. Ricky will be speaking at the 3D Printing in Space panel at the upcoming 3DHEALS2020.
His complete more in-depth written interview can be found here.
Ricky Solorzano, Co-Founder, and CEO of Allevi – Ricky guides the vision, strategy, and day to day of the company. He has been obsessed with tissue engineering for 10 years, studied Bioengineering at the University of Pennsylvania, and created the world’s first desktop 3D bioprinter out of his dorm room. He has been influential in creating the biofabrication industry and has been a Forbes 30 under 30, Inc 30 under 30, and Business Insider 100: The Creators #65.
Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
Have a complex spine problem? Mike Cordonnier from Carlsmed may have an answer for you. While orthopedic surgeons are no strangers to virtual pre-operative surgical planning, it is a different challenge to also provide a patient-specific implant to fit into the patient, rather than molding patient to fit the device. In this interview with our upcoming 3DHEALS2020 speaker, Mike and I discussed how his company aims to realize medical imaging to patient-specific surgical plan and device, leveraging AI, cloud computing, data, and additive manufacturing (or 3D printing). We also touched upon how the ongoing COVID19 pandemic will change the future of surgery.
Mike Cordonnier is CEO and co-founder of Carlsmed, a San Diego based Med Tech company. Carlsmed’s Corra system utilizes predictive analytics to create patient-specific surgical plans and 3d printed implants to improve patient outcomes for spine surgery. Mike has held various leadership roles for large MedTech companies NuVasive, Zimmer Biomet, and Orchid Orthopedics as well as early-stage startups Ellipse Technologies and X-Spine Systems. Mike is passionate about leveraging technology to improve patient outcomes and decrease the cost of healthcare. Mike has a B.S. in Mechanical Engineering from the University of Dayton. Mike will be a speaker for 3DHEALS2020 Orthopedic Panel.
Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
3DHEALS2020 Dental Ambassador Dr. Nabeel Cajee did a quick ice-breaker style interview with Dr. Devic Zille, Director of Applied Innovations at OsteoMed. How can 3D Printing make oral surgeons' lives easier using well-designed 3D printed solutions? Previously an oral surgeon himself, Dr. Zille is working on incorporating 3D printing as a part of a virtual surgical planning solution.
Dr. Devid Zille leads the Patient-Specific Implant initiative for Osteomed, one of the world’s largest small-bone implant manufacturers, dealing with Maxillofacial, Neuro, and Extremities surgery. He is post-graduate in Oral and Maxillofacial Surgery mainly focused on the correction of facial deformities. His expertise includes 3D modeling and design using advanced concepts like lightweight structures and topological optimization based on FEA analysis and 3D printing. Dr. Zille will be speaking on the 3D Printing for CMF panel in the upcoming 3DHEALS2020.
He also authored an Expert Corner blog for 3DHEALS.com previously here.
Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
In the midst of the COVID-19 pandemic, we are fortunate to have a few minutes to interview Dr. Chaw Sing Ho, co-founder and managing director of NAMIC (National Additive Manufacturing Innovation Cluster) of Singapore, which is an organization comparable to America Makes in the United States. This ice-breaker style interview explores Dr. Ho's personal journey to co-founding NAMIC; what drives him behind his work with NAMIC, and how NAMIC works to accelerate adoption and innovation in 3D printing in Singapore, in alignment with Singaporean economic development, as well as how NAMIC is doing to mitigate supply chain crisis in this pandemic. The interview also briefly touches upon resources available to 3D Printing startups (either internal or external to Singapore) from NAMIC.
Guest Biography:
Chaw Sing Ho is the co-founding Managing Director of NAMIC (National Additive Manufacturing Innovation Cluster), a Singapore government initiative to catalyze innovation and scale industrial adoption of additive manufacturing technologies. By focusing on industrial applications and translational R&D, together with commercial strategies to co-create innovative products and services, the national initiative aims to position Singapore as one of the leading digital manufacturing hubs in the era of digitalization and smart factories. Since its inception two years ago, NAMIC has raised more than $24 million in public-private funding to support various AM initiatives across industry verticals.
Prior to NAMIC, he oversaw IP Innovation Strategic Partnerships at HP Singapore. Before that, he was the global head of manufacturing supply chain operations and product innovation for the consumer inkjet supplies business in HP. Chaw Sing started his career in the semiconductor industry with Chartered Semiconductor and Globalfoundries, where he undertook various leadership and customer-facing roles in technology development and engineering operations.
Chaw Sing holds a doctorate in Electrical and Computer Engineering and a Bachelor’s (honors) degree in Electrical Engineering majoring in Microelectronics from the National University of Singapore (NUS). He is an avid inventor with several US/international patents. An advocate for 3D Printing and its role in the new economy, he has spoken in various forums and workshops. He mentors a number of start-ups in the digital and healthcare space. He sits on a number of advisory and expert committees and is an appointed mentor under the GE Digital ASEAN Startup and Partner Program. He is personally interested in nurturing deep tech start-ups, as well as advancing STEM education and engineering as a profession. In his free time, he enjoys sports, movies, reading, and spending time with his family. Dr. Chaw Sing Ho will be a speaker at 3DHEALS2020.
Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
We are fortunate to have Steve Kranz, a senior material scientist at Origin to chat about his life journey as a material scientist for 3D printing, what is an Open Additive Production system, how Origin pivoted in this pandemic and his various hobbies outside of work, including his life long interest in being a storyteller, and a recent publication of a memoir of a prisoner ( "Archie: Gold in the Fire" ). Steve will be a speaker at the material science panel at 3DHEALS2020 in June 2020.
The rest of Steve's more in-depth written interview can be found here.
Guest Biography:
Steve Kranz has been the senior scientist and lab manager at Origin since 2017. Before joining Origin, he worked on the Autodesk Ember 3D Print team in 2016. From 2013-2015, he worked with Prof. William Hammack to write, edit and produce educational engineering videos for the EngineerGuy Youtube channel. In 2013, he graduated from the University of Illinois at Urbana-Champaign with an MS in Materials Science and Engineering.
Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
A lot of us started our journey in healthcare 3D printing accidentally. Listen to this ice-breaker style interview with Dr. Shafkat Anwar, Pediatric Cardiology Director of Cardiac MRI, as well as Co-Founder and Co-Director of the UCSF Center for Advanced 3D+ Technologies (CA3D+). Hear his story on how 3D+ Technologies beyond 3D printing is helping patients (and their families) fighting against congenital heart disease and how UCSF 3D+ Lab is combating against the ongoing pandemic. His full written interview can be found here. He will be speaking at "Point of Care" panel at the upcoming 3DHEALS2020 in June, 2020.
Dr. Shafkat Anwar (Twitter: @ShafkatAnwar) is a pediatric cardiologist with a specialty in non-invasive cardiac imaging, including echocardiography and cardiac magnetic resonance imaging (MRI).
He is the Pediatric Cardiology Director of Cardiac MRI, as well as Co-Founder and Co-Director of the UCSF Center for Advanced 3D+ Technologies (CA3D+). He is a founding member and the inaugural Chair of the Advanced 3D+ Visualization Special Interest Group in the Society for Cardiovascular Magnetic Resonance. He is a consultant at Printerprezz, a medical start-up in Fremont, CA utilizing additive and other advanced manufacturing technologies to develop the next generation of medical devices. At Printerprezz. Dr. Anwar serves as the Senior Vice President of Medical Innovations. Dr. Anwar completed his internship and residency in Pediatrics at Children’s National Medical Center, as well as a research fellowship at the National Institutes of Health. He completed fellowships in Pediatric Cardiology and Cardiac Imaging at Cleveland Clinic and Children’s Hospital of Philadelphia. Prior to joining UCSF, Dr. Anwar was the Cardiology Director of Cardiac MRI at Washington University in St. Louis, St. Louis Children’s Hospital. At Wash. U. Dr. Anwar co-founded and co-directed the Center for 3D Printing, a multi-disciplinary 3D printing center. He will be speaking at "Point of Care" panel at the upcoming 3DHEALS2020 in June, 2020.
Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
In this ice-breaker style interview, upcoming 3DHEALS2020 speaker Dr. Gustavo Mendonça shared with us (Dr. Cajee) on where digital dentistry and dental 3D printing are in restorative dentistry and in the future of dental education. The two also briefly discussed the potentially important role bioprinting and biofabrication can play in restorative dentistry. See full written, video, podcast version of this interview here.
Dr. Gustavo Mendonça received his DDS in 1999 from the University of Uberlândia – School of Dentistry, Brazil. He also completed his postgraduate training in Prosthodontics and a Masters Degree in Oral Rehabilitation from the same school in 2003. In 2008 he finished his Ph.D. in Genomic Sciences and Biotechnology at the Catholic University of Brasília, Brazil. Dr. Mendonça was an Assistant Professor in the Department of Prosthodontics at Catholic University of Brasília – School of Dentistry with an extra-mural private practice from 2003-2007. From 2008 to 2010 he completed post-doctoral research training at UNC-Department of Prosthodontics in the Bone and Mineralization Laboratory. Dr. Mendonça currently teaches in the Comprehensive Care VIC Clinics and the fixed and removable prosthodontics preclinical courses. Dr. Mendonça’s current research interests include the effect of nano- and micro-topography on osteoblast behavior, mesenchymal stem cell differentiation into osteoblasts and the molecular basis of dental implants osseointegration. Clinical research interests include replacing missing teeth with dental implants, evaluating the longevity of implant treatment and CAD/CAM restorations. Dr. Gustavo Mendonça will be speaking at the upcoming 3DHEALS2020, June 5th-6h, 2020, along with other 40+ world-class speakers.
Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
Mike Vasquez is a 3D Printing expert specializing in pushing the boundaries of advanced 3D printing technology. He is the Founder and CEO of 3Degrees, a Chicago-based consulting company focused on helping organizations maximize their investment in the technology. Over the past decade, he has worked side-by-side with some of the top machine manufacturers, material producers and end-users in the industry, consulting with them to identify novel applications, test new materials, and develop frameworks to maximize R&D efficiency and boost ROI. In the past 18 months, Mike has worked with a dozen companies to help them set up successful and safe facilities. He has also created a software tool called TRACE. It aims to assist companies formalizing their use of 3D Printing to ensure they can meet quality and technical standards outlined by their supply chain and industry requirements. He completed his Ph.D. in Additive Manufacturing at Loughborough University and received both his Bachelors's and Masters from MIT in Materials Science and Engineering.
Mike will be speaking on the material science panel at 3DHEALS2020.
Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
In this episode, we are fortunate to have a few minutes with Dr. Albert Woo (in between surgeries) to learn more about his journey in 3D printing as a plastic surgeon and how he was able to work with healthcare organizations and find resources for his innovative work in the space, not just in plastic surgery but other specialties as well. Albert will be speaking on the CMF panel during 3DHEALS2020 virtually in June. Full written, video, audio interviews can be found here.
Albert S. Woo, FACS is a board-certified plastic and reconstructive surgeon who specializes in the treatment of cleft and craniofacial anomalies. This work has led to a particular interest in three dimensional imaging and printing of complex surgical models. He is an Associate Professor of Surgery, Pediatrics and Neurosurgery at The Warren Alpert Medical School of Brown University and serves as the Chief of the Division of Pediatric Plastic Surgery, Director of the Cleft and Craniofacial Center at Hasbro Children’s Hospital, and Director of the new Lifespan 3D Printing Laboratory.
Besides medical 3D printing, Dr. Woo’s clinical interests include the surgical treatment of patients with craniosynostosis, complex and syndromic craniofacial abnormalities, and cleft deformities. In particular, he is internationally recognized as an expert in cleft palate repair, after having developed a new surgical technique for this procedure. He is also a nationally recognized for his expertise in Endoscopic Craniosynostosis Surgery, with numerous papers and national presentations on the subject. With more than 60 peer-reviewed publications, numerous chapters and a book, Dr. Woo remains committed not only to clinical excellence but also to advancing research in the treatment of craniofacial anomalies.
Dr. Woo currently is a member of numerous societies including the American College of Surgeons, the American Society of Maxillofacial Surgeons, the American Cleft Palate-Craniofacial Association, the American Association of Plastic Surgeons, and the American Society of Plastic Surgeons. He is the recipient of numerous awards, including recognition by Best Doctors in America since 2011 and Castle Connolly’s Top Doctors. Dr. Woo recently co-founded a startup, Implant3D.
Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
Today I had the opportunity to interview upcoming 3DHEALS2020 speaker, Roger Kuan, an intellectual property attorney who specializes in 3D printed medical devices and bioprinting innovations. Roger shared his perspectives on how a startup should approach legal help, what COVID19 could impact IP law and startups in the healthcare and other pearls of wisdom.
Roger's more in-depth written interview can be also found here.
Roger Kuan is a partner with McDermott Will & Emery and he focuses his practice on intellectual property (IP) procurement/portfolio management, IP transactions and strategic IP counseling for life sciences clients (e.g., research tools, analytical instrumentation/software, medical devices, diagnostics, biomanufacturing systems, etc.) with a focus on emerging technologies such as digital health (e.g., mobile apps, clinical decision support software, digital therapeutics, AI/ML imaging diagnostics, etc.), personalized medicine (e.g., genomic sequencing platforms, AI/ML computational genomics/bioinformatics, molecular diagnostics, etc.) and 3D printing/bioprinting. He has extensive experience in intellectual property strategy and management, preparation and prosecution (utility/design patents, trademarks, and trade dress), counseling and litigation, licensing and technology transactions, freedom-to-operate clearances, monetization, IP due diligence, IP risk recognition and mitigation, and dispute resolution. He served as Director IP Counsel at a multinational biotechnology company, where he managed a team to support the worldwide IP needs of the company’s life sciences tools, bioproduction/biomanufacturing, molecular diagnostics, and nucleic acid sequencing system/software platforms. Prior to finishing his law degree, Roger worked in the life sciences industry for several Fortune 500 pharmaceutical, medical device, and chemical companies. He has held professional positions in the R&D, sales, engineering, and regulatory affairs organizations.
Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
A short interview with 3DHEALS2020 bioprinting panel speaker, Jordan Miller, co-Founder and CEO of Volumetric, and Professor at Rice University. Volumetric's light-based bioprinting platform was featured on the cover Science last year. In this episode, Jordan shared what motivated him to tackle tough problems like organogenesis for transplant, his perspective on how biology, art/design, and 3D printing have always worked together in the field of tissue engineering, his thoughts on how his background and vascularization projects can help the COVID19 pandemic, plus his late experience as a graduate of YC Class 2020. Full written interview is here.
Jordan Miller is an Assistant Professor of Bioengineering at Rice University and Co-Founder of Volumetric, a Houston-based startup focused on next-generation biomaterials and biofabrication technologies. Miller received his bachelor’s degree in Biology from MIT in 2003 and earned his Ph.D. in Bioengineering from Rice University in 2008. His primary interests combine synthetic chemistry, 3D printing, microfabrication, and molecular imaging to direct cultured human cells to form more complex organizations of living vessels and tissues for research in regenerative medicine. Precisely engineered in vitro systems at the molecular, micro- and meso-scale are well suited to decouple the relationship between tissue architecture and cell function. These systems are now permitting comprehensive closed-loop design and optimization of large-scale engineered tissues through refinement with computer models of mass transport and assessment of their therapeutic potential in vivo.
Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
3DHEALS Dental Ambassador Dr. Nabeel Cajee interviews Judith Thomas, who currently leads the dental 3D printing efforts at Origin, an SF 3D printing startup. Judy shared with us her experience with digital dentistry in the past 20+ years, how she got into 3D printing (surprise!), and what she and Origin are working on during the COVID19 pandemic. Judy will be part of the Dental 3D Printing panel in the upcoming 3DHEALS2020, global healthcare 3D Printing Summit.
Guest Biography:
Judith Thomas-Account Executive for Origin. Origin is a manufacturer of an open platform solution for additive manufacturing. Judith has represented leading companies such as 3M and Carbon in serving the dental market for 20 years. Her expertise includes both clinical and manufacturing applications related to a broad range of dental applications utilizing advanced materials and technology including nano-technology, zirconia, cad/cam, lasers, implant dentistry, and additive manufacturing. Dentistry has been her passion as she has been able to work with cutting edge materials and manufacturers directly impacting both dental professionals and patients. Technology and materials should provide solutions which, minimize complexity and enhance our world.
Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
An inspiration and candid conversation between Dr. Mayasari Lim and upcoming 3DHEALS2020 speaker John O'Neil, Chief Scientific Officer of Xylyx, a New York-based startup focusing on creating the perfect cell environment for a variety of biotech process including biofabrication/bioprinting, and tissue engineering. More specifically, Xylyx aims to translate the cell-specific extracellular matrix into biomaterial products with real-world impact. In this short interview, John shared with us his story of co-founding Xylyx, his vision for the future of bioprinting and tissue engineering, and lessons he learned from past successes and failures. John will be speaking with other startup founders and scientists on the Biofabrication Ecosystem panel on June 6th, 2020 at 3DHEALS2020.
Guest Biography:
Dr. John O’Neill is an expert on biomaterials and tissue- and disease-specific models aimed at transforming drug discovery. He has published extensively in the areas of extracellular matrix (ECM), stem cell research, cell and tissue engineering, regenerative medicine, whole organ recovery and bioengineering, and the use of biomaterials in research, drug discovery and clinical applications. He is an inventor/co-inventor on over 10 issued and pending patents in biotechnology and imaging systems. Dr. O’Neill developed Xylyx Bio’s proprietary platform technology while completing his Ph.D. in Biomedical Engineering at Columbia University in the Laboratory for Stem Cells and Tissue Engineering under Gordana Vunjak-Novakovic, a world leader in tissue engineering, with expertise in regenerative medicine, translational stem cell applications, and disease modeling.
Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
Check out this informative interview between Dr. Mayasari Lim (Roosterbio/3DHEALS) and Adam Feinberg, Professor at Carnegie Mellon University, CTO and co-founder at FluidForm. Learn how Adam first got into 3D printing and bioprinting (years ago!), and how his team at CMU discovered the FRESH technique. Adam also shared his view on how to stay critical of convention and learn to think outside of the box. Adam will be speaking at the Organogenesis/Bioprinting panel at 3DHEALS2020 in June 2020.
Guest Biography:
Dr. Adam Feinberg is CTO and co-founder of FluidForm. The core technology of FRESH printing was developed in his Regenerative Biomaterials and Therapeutics lab at Carnegie Mellon University (CMU), where he is a Professor in the Departments of Biomedical Engineering and Materials Science and Engineering. His group develops materials-based, engineering strategies to control the self-organization and assembly of various cell types into tissues. Adam earned his Bachelor of Science in Materials Science and Engineering from Cornell University, and his MS and PhD in Biomedical Engineering from the University of Florida. He performed his postdoctoral work at the School of Engineering and Applied Science at Harvard University. He holds more than 20 US patents and patent applications, has authored over 45 publications, and is a member of the Materials Research Society, American Chemical Society, Society for Biomaterials, Biophysical Society, Biomedical Engineering Society, and the American Heart Association.
Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
A fun interview with Rachel the Commercial Innovation Manager of ISS/CASIS on her earlier life as a scientist at NASA Ames Research Center, on why working with ISS/CASIS is even more relevant today to all of us, and how it has already had early successes in the commercialization of a few late projects. Rachel also shared with us the challenges we are facing towards scaling such activities and what it is like to attend a party of a rocket launch. Her full written interview is published here. Rachel will be speaking at 3DHEALS2020 **(and answering questions) on microgravity/ISS for 3D printing directly.
Rachel Clemens** has focused her career on advancing life science research and product development through experiments in space. In her current role as a Commercial Innovation Manager at the ISS US National Lab, she brings life science research to low earth orbit. She leads partnership development with life science companies – she finds that every sector, from start-ups to big pharma, can benefit from research in space. She is eager to entertain even the craziest of ideas and passionate about finding new solutions to Earth-bound problems.
After earning a PhD in Molecular Biology from Oregon Health and Science University, Rachel became a Scientist at NASA Ames Research Center leading research on how microgravity affects host-immune systems and microbial pathogenesis. In addition to her current role at the National Lab, Rachel volunteers as a Scientific Project Manager at the Rare Genomics Institute, which connects rare disease patients around the world and provides tools and support to the greater rare disease community. She is based in San Francisco, CA where she blazes trails on foot, conquers hills by bike, and bravely hosts dinner parties in her micro-studio.
Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
In this follow up interview to Dr. Evin Chen's written interview with us, we learned a lot more about why Taiwan could be an excellent center for healthcare 3D printing and bioprinting innovations.
Dr. YiWen Chen (or Evin Chen) received her M.S. and Ph.D. degrees in Industrial and Manufacturing Engineering (Nanomaterial Group) Florida State University, USA. She joined China Medical University Hospital and funded the 3D Printing Medical Research Center in 2014. She is responsible for leading the team and developing and implementing the 3D printed medical research and clinical application integration. She is also the Associate Professor of Graduate Institute of Biomedical Science at China Medical University since then. Dr. Chen’s research interests focus on developing and delivering advanced and affordable 3D printed medical care including biomedical devices, implants, and therapeutics for medical applications. Several of her patents and technologies have to tech-transfer to industries. She was awarded the 2017 and 2018 Innovation in Taiwan. She is also a member of the Board of Supervisors of the Additive Manufacturing Association in Taiwan(AMAT) and a board of directors of China Medical Derivatives Corporation – Everyoung Biomedical International. She is responsible for providing relevant technical advice and is often invited to serve as lecturers at many international academic conferences. Many achievements of her research team are also recognized by high-impact journals, media, conference scientific publications, and published works. She has published 35 peer-reviewed articles and holds 15 issued/pending patents. Dr. Chen will be a speaker for the upcoming 3DHEALS2020 conference.
Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
Join me for a fascinating conversation with 3DHEALS2020 speaker, Kevin Caldwell, CEO and co-founder of Ossium Health, a startup building a bone marrow bank, and providing solutions to more available bone marrow transplant and other related cell therapies. Learn more about Kevin's personal journey as an entrepreneur, how such a bone marrow/stem cell band from organ donors can help biofabrication and tissue engineering, and the bioethical concerns with cell therapy and tissue engineering. The video version of this interview can be found here. Stay tuned for more in-depth written interview with Kevin at 3DHEALS.com.
Guest Biography:
Kevin E. Caldwell II is the Co-founder, President & CEO of Ossium Health, where he leads a team that is building the world’s first bone marrow bank. Kevin previously worked in consulting as an Engagement Manager at leading strategy consulting firm
McKinsey. Prior to that, he served in the Quantitative Research department of the hedge fund Bridgewater Associates. Kevin was trained in Physics and Economics at MIT before receiving his JD from Harvard Law School.
Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
A fascinating conversation with upcoming 3DHEALS2020 speaker Dr. Stephanie Willerth on where bioprinting and biofabrication technology is to help with drug development and screening of neurological diseases such as Alzheimer's disease if we can create tissue replacements, "mini-brain", as well as her new bio-ink startup, Axolotl Biosciences.
See the full interview here.
Dr. Willerth holds a Canada Research Chair in Biomedical Engineering at the University of Victoria where she has dual appointments in the Department of Mechanical Engineering and the Division of Medical Sciences as an Associate Professor.
She serves as the Acting Director for the Centre for Biomedical Research at the University of Victoria and on the steering committee of the B.C. Regenerative Medicine Initiative. She also served as the President of the Canadian Biomaterials Society from 2017-2018. Her honors include being named the 2018 REACH award winner for Excellence in Undergraduate Research-inspired Teaching, a Woman of Innovation in 2017, one of the 2015 Young Innovators in Cellular and Biological Engineering and a “Star in Global Health” by Grand Challenges Canada in 2014. She spent Fall of 2016 on sabbatical at the Wisconsin Institute for Discovery supported by the International Collaboration on Repair Discoveries International Travel Award where she wrote her book “Engineering neural tissue using stem cells” published by Academic Press.
She completed her postdoctoral work at the University of California-Berkeley after receiving her Ph.D. in Biomedical Engineering from Washington University. Her undergraduate degrees were in Biology and Chemical Engineering from the Massachusetts Institute of Technology. Dr. Willerth will be speaking at the upcoming virtual 3DHEALS2020.
Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
In this interview, professor Nick Dechev shared with us the history of Victoria Hand Project, a nonprofit organization focusing on 3D printed upper limb prosthetics. Nick shared with us the technologies and the people behind it, and how the organization is making an impact in eight developing countries and now moving into underserved communities in the U.S. and Canada with new funding.
Nick Dechev received his Ph.D. in Mechanical Engineering from the University of Toronto, Canada, in 2004, and joined the University of Victoria in 2005. He is currently an Associate Professor in the Faculty of Engineering and is presently Director of the Biomedical Engineering Program. Dr. Dechev’s research program involves biomedical system design with application areas centered on advanced hand prosthesis and bio-sensor design. These areas include 3D printing of hand prosthesis, implantable sensor design for the acquisition of bio-signals, and wireless power transfer technology for implantable sensors. These projects aim at developing better methods for the control of advanced hand prosthesis. He is also the Executive Director of the Victoria Hand Project, a non-profit dedicated to providing hand prostheses to amputees in need in developing countries. Professor Dechev will be a speaker at the #3DHEALS2020 conference focusing on point of care 3D printing with his work with VHP.
Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
Fluidform, a bioprinting startup, successfully printed heart valves using the FRESH technique and new biocompatible materials. In this short interview, Mike Graffeo, CEO of Fluidshorm shared with us this amazing technology, challenges and opportunities with regulation, scalability, and commercialization of tissue engineering /regenerative medicine products in general.
Mike Graffeo, CEO, Fluidform
A senior executive with a proven track record in commercialization of innovative medical technology, Mike is a results-oriented, decisive leader with a track record of successfully growing new businesses in both startup and growth organizations. Throughout his career, he has gained extensive experience translating highly complex devices and clinical data into successful businesses, both in the US and globally. Mike holds a BS in Engineering Physics and an MEng in Mechanical Engineering from Cornell University, as well as an MBA from Harvard Business School. Mike will also be speaking at the upcoming 3DHEALS2020 San Francisco on June 5-6th, 2020, along with 40+ other world-class speakers.
See full video, audio, written interview here.
Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
Dr. Jenny Chen Interviewed Stefan Leonhardt, Managing Director of Kumovis, also our upcoming 3DHEALS2020 speaker, on how he and his company in Munich Germany, are coping with COVID-19, the future of Kumovis, 3D Printing material science, and point of care using 3D Printing.
Full written, video and audio interviews can be found on 3DHEALS.com here.
Guest Biography:
Stefan Leonhardt studied medical engineering at the Technical University of Munich. His research during his studies was focused on the influence of materials and manufacturing processes on the biocompatibility of polymer parts.
In 2015 he started his Ph.D. program at the Institute of medical and polymer engineering at the Technical University of Munich, about the development of a biocompatible photopolymer for the production of individualized bioreactors used in tissue engineering processes.
Since October 2017 he is a managing partner of the Kumovis GmbH, a startup that develops innovative 3D-printing systems for the production of individualized implants out of PEEK. Stefan will be speaking at 3DHEALS2020.
Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
Dr. Mayasari Lim has been the 3DHEALS bioprinting ambassador since 2017. She was one of a few female bioprinting founders (SE3D), and now she is in her new role at RoosterBio. Hear her thoughts on entrepreneurship, bioprinting startups, future of biotech, and overview of the 3DHEALS2020 biofabrication programming.
About Our Co-host Dr. Mayasari Lim:
Dr. Mayasari Lim is the West Coast & APAC Regional Account Manager for RoosterBio and an active contributor to the stem cell and bioprinting community. She was the founder and CEO of SE3D, a startup focused on bringing bioprinting into the classroom to support future workforce development. And previously, she was an assistant professor in Bioengineering at Nanyang Technological University in Singapore with a research focus in stem cell bioprocess engineering, bioprinting, and regenerative medicine. She has also served as an adjunct lecturer at the Fung Institute for Engineering Leadership at UC Berkeley. Dr. Lim obtained her Ph.D. degree in Chemical Engineering at Imperial College London and her B.Sc. in Chemical Engineering at UC Berkeley.
Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
Dr. Jenny Chen (3DHEALS) interviews 3DHEALS2020 software design panelist Gavan Wilhite, an interesting conversation on how game developers have huge potential role in future biofabrication software design, fascinating VR world and how that translates into Gavan's eventual desire to have a bigger impact in the physical world he is part of, and last but not the least, how generative design can play a big role in future design software development.
Gavan Wilhite, Founder AltspaceVR
Gavan Wilhite has spent his career leveraging video game technology to create a positive impact in other industries. He helped reinvent educational games at Disney, founded AltspaceVR, a social virtual reality company that was acquired by Microsoft, and is a Forbes 30 Under 30 recipient. Originally from Honolulu, he now lives in San Francisco where he is building 3D generative modeling tools to accelerate tissue engineering.
Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
Dr. Nabeel Cajee is a thought leader in 3D Printing in dentistry and healthcare. He is the Dental Ambassador of 3DHEALS; a healthcare 3D printing innovation platform. He directs the PRINTtoPROTECT Coalition, a COVID19 emergency PPE 3DPrinting effort in California’s Central Valley which aims to produce 10,000 face shields for frontline workers. He is recognized as a Master of the International Congress of Oral Implantology and Fellow of the American Academy of Implant Prosthodontics. Dr. Cajee maintains a private practice in Manteca, CA where he focuses on implant and complex dentistry. Dr. Cajee is a speaker for 3DHEALS2020.
Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
Hear our exclusive interview with Mr. Kuntay Aktas, Co-Founder of BTech Innovation
"I am a passionate technology executive, leader, and strategist. I am an expert in additive manufacturing, medical 3D Printing, AM technology implementations, and applications.
I am the co-founder of BTech Innovation and currently working as CEO of the company. During my years at BTech Innovation, I’ve had the privilege of working with global companies (USA, UK, Germany, Sweden, France, Belgium, Italy, Latvia, Netherland, Canada) and technology experts as a representative, consultant, and partner all around the World.
I have the ability to manage multi-disciplinary projects and to navigate complex challenges. I have always been an integral part of the BTech team who succeed in many global case studies, awards and projects and became leading engineering companies in the additive manufacturing industry. I will be speaking at 3DHEALS2020. "
Full in-depth written and video interview can be found here.
Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
Shannon Walters is an innovation enabler and workflow-optimization enthusiast. At Stanford 3D and Quantitative Imaging Lab, Shannon works closely with healthcare providers, researchers, and educators to enable effective health visualization. Recent innovations are of particular interest to Shannon such as 3D Printing, immersive volumetric visualization, and concise reporting of changes over time. Mr. Walters will be a speaker on "3D Printing for Point of Care- Stanford Experience" for our upcoming June virtual conference 3DHEALS2020. Here is a recording of our interview with Shannon.
Full in-depth written interview can be found here.
Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
There are literally hundreds of 3D printing designs to support the current COVID19 response. Some work, others don’t. Some look great but do not work. 3DHEALS invited several top additive manufacturing designers who have been very active throughout the COVID-19 crisis to speak at this 1.5-hour webinar. Full speaker detail here. Attendees from 16 countries participated in this webinar.
Click here for show notes.
Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
Mr. Joshua Neubert has extensive experience managing entrepreneurial non-profit organizations, incentive prize competitions, educational programs, and startup enterprises. In 2012, he founded the Institute of Competition Sciences to create an online community and support system for academic competitions. His passions center on accelerating science, technology, and learning to make the world a more knowledgeable and inspiring place. Through the Institute of Competition Sciences, Mr. Neubert developed the Summit on Incentivized Innovation, launched the first collaborative community for challenge-based- learning, and helped develop and manage high-profile prizes providing over $8,000,000 in awards through partnerships with the Cleantech Open, Lemelson Foundation, NASA, Ideas42 and the Robinhood Foundation, Goodwill, Duke University, New Mexico State University, the Methuselah Foundation, the Actuarial Foundation, and others. Mr. Neubert has been a National Science Foundation Principal Investigator and has organized science, technology, engineering, and mathematics policy workshops with the NIH, HHS, NSF, NASA, and White House OSTP among others. Prior to founding ICS, Mr. Neubert helped NASA launch a $1.5 Million energy storage competition for advanced aerospace technologies. He previously led a team of over 500 volunteers and staff at the X PRIZE Foundation to create a STEM education program reaching 12,000 students. During this time, he developed the Spirit of Innovation Awards – a science and technology entrepreneurship competition for high school students – and later helped spin the program out as its own foundation built upon the legacy of Apollo 12 Commander Pete Conrad. He served as the founding Executive Director of the Conrad Foundation and launched the program into schools across the country reaching over 3000 students in its first three years. Mr. Neubert has designed and led grand challenges, hackathons, game jams, and other incentivized innovation programs for over 10 years and has served as Founder and CEO of the Institute of Competition Sciences since its founding in 2012. He was trained as a Planetary Scientist at the Massachusetts Institute of Technology and continues to hold space science and exploration as a passion in his life. Mr. Neubert is a regular instructor, public speaker, and lecturer in entrepreneurship, innovation, and education topics particularly related to science and technology fields. Josh will be speaking at 3DHEALS2020. Here is a recording of Dr. Mayasari Lim interviewing Josh on his work with NASA and biofabrication. Full in-depth written and video interviews can be found here.
Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
Dr. Rui Coelho“I’ve started as a DDS, jumping almost immediately to maxillofacial surgery, I’ve taught dental implantology at the University from 1993 to 1998, a post-graduate program. From 2011 I’ve dedicated to the Industry as a project manager for some projects including “Digital stratification of dental crowns”. The project was developing a 5-axes 3D printer to make stratification of dental crowns with composites by 3D printing.
In 2013 I’ve found two companies “Tailoredimplant” and “Boneeasy”, the first was to develop 3D software for surgeons designing bone grafts and the second one a bioprinting company that prints implantable medical devices.”
Dr. Coelho will be speaking on the dental panel at 3DHEALS2020.
Here is a short recording of Dr. Nabeel Cajee Interviewing Dr. Rui Coelho. Full in-depth written and video interviews can be found here.
Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
Over the years Dr. Kevin Yoder has been immersed with computers and technology, which he quickly developed a fierce passion for. He coded his first application when he was in the 7th grade, and continued on until he received his undergraduate degree in computer science.
After completing his dental degree and settling into private practice, Dr. Yoder immediately saw the need for many technological advancements in the field of dentistry and made it his second full-time job to raise the bar for the profession. Since then, Dr. Yoder has spent countless hours researching, prototyping and experimenting with various modalities of technology, trying to determine what the best and cheapest methods are to universally advance dentistry as a whole. He prides himself on his software development skills, a thorough understanding of CAD/CAM and streamlining workflows for digital dentistry. Dr. Yoder will be a speaker at 3DHEALS2020 .
Here is our short interview recording between 3DHEALS dental ambassador Dr. Nabeel Cajee and Dr. Kevin Yoder.
Read the more in-depth exclusive interview here.
Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
Firoza Kothari started her journey to provide patient-specific medical solutions and one day end the organ donation problem by creating live organs out of patients’ stem cells. With that aspiration, she gave birth to Anatomiz3D. She, along with her team, was the first to execute soft tissue models in India through Paediatric Cardiology, partial amputee prosthetic hand, first kidney tumor case in India, and the model for tongue cancer was the first in the world. Being a Co-founder and CTO of Anatomiz3D, she, along with her team, has successfully added 700 plus case studies. Her multi-disciplinary expertise prevails in converting 2D DICOM CT/MRI/Echo Scans to 3D Printed anatomical replicas, medical devices, and allied products, using various combinations of Hardware and Software, across multiple medical specializations. Anatomiz3D has played a vital role in creating the market for 3D Printing in the Medical industry in India and are pioneers for the same. Firoza will be speaking on her experience of Point of Care at 3DHEALS2020.
Here is our short interview recording between 3DHEALS founder Dr. Jenny Chen and Firoza Kothari from Anatomiz3D.
Read here for a more in-depth exclusive interview.
Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)
This was an Ask Me Anything (AMA) format free webinar inviting 3DHEALS2020 speakers to have a direct and candid conversation that took place on April 4th, 2020, 8 AM PST. Please click here to learn more about the panelists and show notes/links.
There are numerous parallel conversations throughout the healthcare 3D Printing sector lately on how the industry can collectively help with the current crisis. The intrinsic advantages of 3D printing solve the supply chain crisis the healthcare sector is experiencing by allowing decentralized manufacturing processes, design freedom, and lack of inventory requirement. That said, what design should we use? Who are the qualified manufacturers? What does the healthcare system really need? What 3D printing can or cannot do? Are we helping?
We welcome you to join this direct and candid conversation with us in this Free webinar. The first half of the webinar is a conversation among invited world experts. The second half is open to public Q&A, moderated by 3DHEALS.
Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)